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ABSTRACT 
One of the most common of deficits observed in Fetal Alcohol Spectrum Disorders (FASD) is 
difficulties with attention. Because attention deficits are commonly treated with stimulants, the 
impact of d-amphetamine (AMPH) treatment during the juvenile period in an animal model of 
FASD was examined. A dose-response study first assessed the appropriate dose of AMPH to use.  
In the dose-response study, therapeutic doses of 0.5, 1.0, and 2.0 mg/kg/day of AMPH were 
chronically administered to female rats between postnatal days (PD) 26-40. Rats were subjected 
to an open field test on the first and last day of treatment. The dose of 1.0 mg/kg/day was the 
lowest dose which resulted in significant behavioral sensitization and therefore was selected for 
the FASD study. In the FASD study, pups were exposed to alcohol between PD 2 and 10. Control 
groups included an intubated control (IC) and a non-treated control (NC). At PD 26, rats were 
randomly assigned to either amphetamine or water treatment for twice-daily subcutaneous 
injections from PD 26 to 41. On PD 26, 27, 40, and 41, an open field test was administered to 
assess locomotion.  On PD 42, the rats were perfused, and the brains were removed and 
prepped for histological measures. The results indicated that amphetamine increased 
distance traveled acutely, and that this effect became greater over days of treatment. 
Amphetamine-treated rats exhibited significantly more rearing behaviors and less 
grooming behavior than water-treated rats. Both rearing and grooming behavior 
decreased over test days. There was no effect of alcohol exposure on any open field 
measures. Dopaminergic and noradrenergic systems were analyzed via
  
vi 
 immunohistochemistry for tyrosine hydroxylase (TH), the dopamine transporter (DAT) 
and dopamine-beta-hydroxylase (DBH). An omnibus ANOVA revealed no impact of 
alcohol exposure or amphetamine treatment on TH or DAT within the nucleus 
accumbens core. Although amphetamine treatment caused a small but significant 
increase in DBH within the medial prefrontal cortex, there was no effect of alcohol 
exposure on this measure. These results suggest that catecholaminergic neurons are 
resistant to the developmental impact of alcohol. However, juvenile amphetamine 
treatment may increase noradrenergic synthesis or innervation within the prefrontal 
cortex, influencing developmental trajectories.  
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CHAPTER 1 
INTRODUCTION 
1.1 ALCOHOL IS A TERATOGEN 
An alcohol is any compound containing a functional hydroxyl group attached to a 
saturated hydrocarbon (Pohorecky & Brick, 1990). Although there are multiple types of 
alcohols, humans typically consume ethyl alcohol, an amphipathic molecule with a 
negatively charged oxygen “head” and a neutral methyl “tail” (Pohorecky & Brick, 1990). 
This amphipathic property allows its distribution throughout bodily tissues, including 
easy passage through the blood brain barrier where it can affect functioning of neural 
systems (Hanig et al., 1972). The result is a state of intoxication. At low doses, alcohol 
intoxication is associated with decreased inhibitions, elevated mood, and impaired 
motor coordination (Davidson et al., 1997). At high levels, intoxication is associated with 
stupor, coma, and potentially death (Sanap & Chapman, 2003). Despite these risks, 
alcohol use transcends cultures. It is the oldest psychoactive compound consumed by 
humans, and vestiges of purposeful distillation can be traced back to the Stone Ages 
(Gately, 2008).  
 Ethanol’s chemical nature poses special implications for pregnant women as 
ethanol can diffuse through the placental barrier to interfere with healthy fetal 
development (Guerri & Sanchis, 1985). Despite the long association between humans
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 and alcohol consumption, the effects of exposure to alcohol in utero weren’t delineated 
in the medical literature until the late 1900s. French pediatrician Paul LeMoine first 
described alcohol-derived birth defects in 1968 after documenting 127 case studies of 
children from alcoholic mothers (LeMoine, 1968). These effects included miscarriages, 
stillbirths, growth retardation, and a constellation of facial malformations. Five years 
later, American pediatricians Jones and Smith independently categorized the effects of 
alcohol exposure in utero with 8 case studies. This article by Jones and Smith (1973) 
launched worldwide investigations into the impact of alcohol on the fetus (Koren, 2012). 
By 1981, the U.S. Surgeon General responded to the emerging body of literature on 
alcohol’s teratogenicity by advising no alcohol consumption during pregnancy (US 
Surgeon General, 1981). As the bodies of literature on the variable effects of alcohol 
exposure in utero have grown, classifications of these effects have expanded to 
encompass this spectrum. These effects are diagnosed as fetal alcohol spectrum 
disorders (FASD) with fetal alcohol syndrome (FAS) referring to the most severe cases.  
 Despite awareness of the teratogenic effects, alcohol remains a widely abused 
substance throughout pregnancy. According to data from prenatal clinics and postnatal 
studies, up to 30% of pregnant women drink during their pregnancy, and 2% binge drink 
(CDC, 2012). Shockingly, these estimates have shown no decline in the last two decades. 
As a result, FASD occurs in approximately 9.1 per 1000 live births with FAS occurring in 
approximately 2 per 1000 live births. Statistically, this makes FASD the most preventable 
source of neurological deficits in the United States (Abel, 1995; Sampson et al., 1997). 
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While the effects of in utero exposure to alcohol are devastating at an individual 
level, society also feels the weight of this burden. Every child born with FAS has a 
staggering economic cost of $2 million, and the U.S. government spends over $4 billion 
in annual care for FAS individuals (Lupton et al., 2004). These numbers increase 
exponentially when economic costs are extended to the entire FASD spectrum. Many of 
these costs are associated with the multiple cognitive and social secondary disabilities 
with FASD children. These secondary problems include functional deficits in problem 
solving, deficits in adaptive function, decreased intelligence quotients, trouble with the 
law, alcohol and drug problems, executive function deficits, and inappropriate sexual 
behavior (Streissguth et al., 2004). However, the most prominent secondary deficits 
associated with FASD are attention deficits.  
Forty-one to 94% of children with FASD will later be diagnosed with attention-
deficit/hyperactivity disorder (ADHD) (Bhatara, Loudenberg, & Ellis, 2006; Fryer et al., 
2007). Comorbidity with ADHD becomes increasingly prevalent with greater exposure to 
alcohol in utero, indicating that alcohol directly interferes with the development of 
attention networks (Bhatara, Loudenberg, & Ellis, 2006). In fact, neonatal attention 
deficits may be a more sensitive indicator of potential in utero exposure to alcohol than 
even the characteristic facial dysmorphology (Lee, Mattson, and Riley, 2004).  
Not only are attention deficits common in FASD children, but onset of these 
deficits are one of the earliest symptoms of cognitive impairments. Streissguth, Barr, 
and Martin (1983) examined approximately 500 one-day-old infants with and without 
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exposure to alcohol using the Brazelton Scale. The Brazelton Scale assesses neonatal 
behavior in general, and some of the measures are associated with attention. 
Socioeconomic status, marital status, age, education, and race were all accounted for to 
rule out confounding factors. Maternal prenatal alcohol consumption was also assessed 
to examine alcohol effects on a dose-response scale. Streissguth et al. discerned that 
neonates from alcoholic mothers had significantly lower states of arousal, poor 
habituation to environmental stimuli, and basic deficits in operant learning. This finding 
provided concrete evidence that developmental problems in FASD children were 
evident even on the first day of life. Early occurring deficits in attention could have a 
dynamic impact on function, aggravating ontogenesis of cognitive skills that mature 
later such as learning and social skills. As a result, early treatment options could 
remediate developmental trajectories in FASD, ameliorating the astronomical impact at 
both individual and societal levels. 
Understanding how alcohol interferes with the development of attentional 
networks and the phenotype of attention deficits in FASD children will inform treatment 
strategies for this population. Therefore, this introduction will examine the relationship 
between prenatal ethanol exposure and one of the most overt behavioral characteristics 
of FASD: attention deficits. The literature on attention deficits in FASD will be reviewed 
in the context of neurobehavioral theories on attention with the argument that FASD 
children exhibit a unique phenotype of attention deficits that is detrimentally masked by 
the indiscriminate diagnosis of ADHD. The unique phenotype of FASD children is argued 
to be the result of distinct changes in underlying neural networks – data which has been 
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elucidated by animal models of FASD. A rationale for the use of animal models of FASD 
will be provided, followed by a discussion of disruptions in catecholaminergic 
transmission in FAS in relation to networks of attention. Because attention deficits are 
primarily treated with stimulant medications, mechanisms of action of the two primary 
stimulant prescriptions, methylphenidate and d-amphetamine, will be compared and 
contrasted in relation to attention deficits and FASD. This literature review will be 
followed by a rationale for the current experiments which examined the impact of 
ethanol and d-amphetamine on developing dopaminergic and noradrenergic systems. 
The overarching hypothesis is that a chronic therapeutic dose of d-amphetamine 
normalizes hypo-functioning dopaminergic and noradrenergic systems in a rat model of 
FASD. 
1.2 ATTENTION DEFICITS IN FASD 
 Attention is an abstract concept with multiple different subcomponents that 
collectively facilitate the selection of relevant information and the suppression of 
irrelevant information. Two models of attention have been used to describe the 
phenotype of attention deficits in FASD populations: Posner (1980) and Mirsky (1991). 
Posner’s model (1980) describes attention as a spotlight which highlights a point 
of interest, then disengages and moves to an alternative point of interest. This analogy 
describes functional components essential to the attentional process: alerting, 
orienting, and executive function. Alerting prepares an organism for processing high-
priority signals. Orienting is the ability to locate a stimulus within a visual or auditory 
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field. Executive function is a heterogeneous term which describes cognitive control 
mechanisms resulting in top-down decision making for the attentional spotlight. 
Alerting and executive function deficits have been extensively documented in FASD. 
At a neurological level, alerting is associated with global levels of arousal and is 
driven by the noradrenergic system. This association has been tested at a physiological 
level in regards to spatial processing. Noradrenergic afferents increase spatial 
processing in the prefrontal cortex (PFC) by inhibiting inputs with similar spatial 
properties, thereby suppressing stimuli that could conflict with the target of interest 
(Wang et al., 2007). Children with FASD have different problems alerting to stimuli 
compared to children with ADHD without FASD comorbidity. This distinction was 
demonstrated by Kooistra et al. (2009) using a Go/No-Go task.  In the Go/No-Go task 
subjects are presented with a predictable stimulus to which they must respond quickly. 
However, in a small subsection of the trials, subjects must inhibit their response (i.e. 
“No-Go” trials). Because No-Go trials are rare, response inhibition is challenging. There 
were two trial rates: a fast rate with short intervals between trials and a slow rate with 
long intervals. ADHD children without FASD comorbidity are sensitive to the stimulus 
presentation rate with more errors and variability in slower conditions. In contrast, 
FASD groups had declining performance in fast-rate conditions. These data indicate that 
children with FASD have more problems handling overstimulation whereas non-FASD 
ADHD children have greater problems handling understimulation. Sensitivity to multiple 
stimuli may reflect changes in noradrenergic arousal systems.  
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Executive function deficits are identifiable even in the absence of facial 
dysmorphology with FASD (Mattson et al., 1999; Green et al. 2009). Green et al. (2009) 
assessed executive function using the Cambridge Neuropsychological Tests Automated 
Battery (CANTAB) and determined that FASD individuals exhibited deficits in multiple 
executive function domains including set shifting, general attention, strategy and 
planning, and spatial working memory. These deficits in executive function were evident 
even in the absence of facial dysmorphology, which is indicative of the most severe 
cases of FASD. Linking these behavioral findings with neural substrates would suggest 
that these deficits are paralleled by deficits in the monoaminergic systems. Indeed, 
animal literature has demonstrated that alcohol exposure induces many monoaminergic 
alterations. Similar to Greene et al. (2009), Mattson et al. (1999) used to the Delis-
Kaplan Executive Function Scale to evaluate planning, cognitive flexibility, selective 
inhibition, and concept formation and reasoning in children with FASD compared to 
children not exposed to alcohol in utero. Deficits in executive function were evident in 
FASD populations even after deficits in intelligence quotients (IQ) were accounted for. 
Additionally, deficits in executive function were evident in FASD children even when IQ 
was within normal ranges. Collectively, these results indicate that executive function 
domains are especially sensitive to the teratogenic effects of alcohol.  
Another model of attention was proposed by Mirsky in 1991 (Mirsky, 1991). In 
this model, attention is comprised of four primary elements: focus, sustain, encode, and 
shift. Focus describes the ability to select information for further, higher-level 
processing. Sustain describes the capacity to maintain focus over the course of time. 
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Shift describes flexibility in attention, such as the ability to adaptively change focus. 
Encode describes the ability to use working memory to manipulate information and 
then transfer that information into long-term memory. According to Mirsky, these 
elements could be partially functionally localized to discrete brain regions. For example, 
Mirsky associated attentional shift with the prefrontal cortex, encoding with the 
amygdala and hippocampus, focus with the inferior parietal lobe, and sustained 
attention with the reticular formation in the brainstem. Using Mirsky’s model, clinical 
diagnoses of attention deficits can be associated with specific brain regions, providing 
targets for both research and clinical intervention strategies.  
In 2006, Mattson, Calarco, & Lang used Mirsky’s model to examine attention in 
FASD populations. Mattson and colleagues demonstrated that FASD children have 
difficulty with attentional shift, visual focused attention, and sustaining auditory 
attention, indicating that attention deficits in FASD extend across many measurable 
domains. Mirsky’s model also provided a basis for comparing attention deficits between 
FASD populations and ADHD populations without FASD comorbidity. These 
comparisons, which will be discussed in the following section, are part of a movement to 
distinguish a unique cognitive profile of FASD populations that can inform treatment 
paradigms.  
Both Mirsky and Posner created models that attempted to subdivide attention 
into specific components and then functionally localize those components to specific 
neural systems and brain regions. These models have provided useful templates for 
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examining attention deficits in the FASD literature from a clinical perspective, informing 
experimental models. However, the phenotype of attentional deficits in FASD 
populations may change across development.  
Hypersensitivity to environmental stimuli and poor habituation are early 
indicators of attentional problems (Streissguth et al., 1983). These deficits in habituation 
shift into attention deficits, as measured by classical attention-based tasks, during early 
school years, and later in life these basic attention deficits become superseded by more 
complex behavioral problems (Streissguth, Martin, & Barr, 1984; Fryer et al., 2007). 
Evidence suggests that attention deficits are especially deleterious to development in 
FASD populations. When examined in conjunction, comorbidity of FASD and ADHD has a 
synergistic effect on future comorbidities (Ware et al., 2013). Specifically, oppositional 
defiant disorder and conduct disorder had a far greater prevalence in ADHD-FASD 
comorbid populations than ADHD populations without FASD or FASD populations 
without ADHD (Ware et al., 2013). Lastly, secondary disabilities increase with age in 
untreated populations of FASD (O’Malley & Nanson, 2002).  
These data suggest that an attentional profile in FASD populations is a 
developmental issue. Understanding manifestations of attention deficits in FASD and 
the differentiation of those attention deficits from ADHD populations without FASD 
comorbidity may provide insight to the impact of different treatments on general 
prognosis. Therefore, this next section will focus on attention deficits in FASD and how 
they compare to attention deficits in ADHD.  
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1.3 THE UNIQUE PHENOTYPE OF ADHD IN FASD POPULATIONS 
Diagnosis of ADHD in FASD populations reflects different attentional subtypes 
than ADHD populations without FASD comorbidity. The Diagnostic Statistical Manual of 
Mental Disorders (5th ed.; DSM-5; American Psychiatric Association, 2013) identifies 3 
major domains in ADHD: (a) Inattentive subtype, (b) hyperactive and impulsive subtype, 
or (c) a combined subtype. Diagnosis of ADHD in FASD populations preferentially reflects 
inattentive subtypes over hyperactive and impulsive subtypes (O’Malley & Nanson, 
2002). These results support the idea of a unique attentional profile of FASD children 
with ADHD. Over the last decade, studies have increased efforts to document 
distinctions between the progression and manifestation of attention deficits in FASD 
children and ADHD with the hope that understanding these distinctions can inform 
treatment of FASD children.  
One of the earliest studies comparing attention deficits in FASD versus non-FASD 
populations with ADHD was performed by Coles et al. in 1997. Coles et al. (1997) 
demonstrated that while children with ADHD but not FASD are best identified using 
measures of focused and sustained attention, children with FASD appear to have 
greater visual and spatial reasoning deficits, encoding deficits, deficits in attentional 
shift, and impaired flexibility in problem solving tasks. 
Crocker et al. (2011) supported differential patterns of cognitive deficits 
between ADHD and FASD children in a study that matched groups on age, sex, race, and 
ethnicity, handedness, and socioeconomic status. FASD children had greater difficulty 
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with encoding of information whereas ADHD children had greater difficulty with 
retrieval. Burden et al. (2010) supported neural distinctions of FASD and ADHD 
populations without FASD comorbidity using event-related potentials (ERPs) during a 
Go/No-Go task. Although children with FASD performed similarly to those with ADHD 
but no FASD comorbidity, ERPs varied between groups, indicating differences in neural 
processing. These distinctions likely reflect differences in underlying neural networks, 
indicating that attention deficits in FASD populations should not be treated the same as 
ADHD without FASD comorbidity. Indeed, some evidence suggests that children with 
FASD respond preferentially to d-amphetamine compared to methylphenidate stimulant 
treatment for attention deficits (O’Malley, 2000). This distinction is not reflected in 
ADHD populations without FASD where methylphenidate is the primary treatment 
option (Zito et al., 2000; Goldman et al., 1998). The relationship between neural 
networks, attention deficits, and treatment strategies need to be further examined so 
neural networks can inform treatment of attention deficits in FASD. Because 
understanding alcohol’s impact on neural networks has primarily been examined using 
animal models, the next section will examine animal models of FASD.  
1.4 ANIMAL MODELS OF FASD  
 A variety of animal models can be used to assess the impact of alcohol exposure 
in utero. These models include zebrafish, rodents, and non-human primates (Patten, 
Fontaine, & Christie, 2014). Rodent models are the most frequently utilized as they 
display high levels of face and construct validity: deficits in rat models of FASD parallel 
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deficits in human models. These parallels extend from physical to neurocognitive and 
behavioral domains. Facial dysmorphology in mice is consistent with human facial 
dysmorphology (Lipinski et al., 2012). Mouse models demonstrated that this 
characteristic of FASD is dependent upon early gestational exposure (Parnell et al., 
2009). Rat models also display impairments in attention, learning impairments, and 
hyperactivity, demonstrating symmetry between attentional phenotypes in humans and 
rats (Hausknecht et al., 2005; Melcer et al., 1994; Stoltenburg-Didinger & Spohr, 1983). 
Rodent models provide several advantages for studying alcohol exposure 
compared to human studies of FASD. Studies of fetal alcohol exposure in humans have a 
number of confounding factors. These factors include but are not limited to 
socioeconomic status, multidrug use, racial differences, genetic predispositions, 
unreliable reporting of drinking patterns, and environmental stress. In addition, human 
studies of fetal alcohol exposure are ethically limited as humans cannot be assigned to 
drinking and non-drinking pregnancy groups. This makes causal relationships between 
ethanol and behavior impossible to determine. Animal models enable a randomized and 
highly controlled examination of how ethanol impacts trajectories of 
neurodevelopment, but in order to replicate human drinking behaviors, several factors 
must be addressed. 
 One major consideration is that human development does not perfectly align 
with rat development with respect to timing of birth (Bayer et al., 1993; Dobbing & 
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Sands, 1979). A comparison of human and rat developmental periods can be found in 
Table 1.1. 
Exposure paradigms in animal models vary across gestation. The third trimester 
of development (PD 1-10) is especially critical as this is considered the brains growth 
spurt (Dobbing & Sands, 1979; Bonthius & West, 1991). There is evidence from both 
animal models (Kelly et al., 1988; Maier et al., 1997; West, Kelly, & Pierce, 1986) and 
also human studies (Rosett, 1981) that the third trimester is a period when the brain is 
particularly vulnerable to insults including ethanol. The current study used a third-
trimester paradigm for alcohol exposure. This exposure paradigm uses intragastric 
intubation, delivering an alcohol-milk enriched mixture directly into the stomach of the 
neonatal rat pups (Kelly & Lawrence, 2008). Alcohol exposure in neonatal rats can result 
in nutritional deficits as the ethanol-exposed pups do not nurse properly. In order to 
compensate for any malnourishment, a second, vitamin-rich intubation should be 
performed. This limits neural deficits to alcohol, specifically.  
 A second consideration for animal models is how to accurately replicate human 
patterns of drinking behavior. The most deleterious type of drinking for fetal alcohol 
development is binge drinking as high blood alcohol concentrations increase the 
severity of neural deficits (Bonthius, Goodlett, & West, 1988). Intubation procedures 
can replicate this drinking pattern with minimal stress to the rat. This type of 
administration allows precise oral doses of alcohol with rapid peak blood ethanol 
concentrations (BEC) which is then eliminated through zero-order effects, as in humans. 
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Intubated control groups who do not receive an ethanol solution provide comparisons 
for the stress effect. Therefore, having three exposure groups (i.e. ethanol treated, 
intubated control, and non-treated control) is essential to examining the effects of 
alcohol on neurodevelopment and later behaviors. 
 Rats are well-suited for behavioral studies due to the plethora of behavioral 
measures that are well established with the species (Cudd, 2005). However, several 
studies suggest that female rats may be more vulnerable to chronic consequences of 
prenatal alcohol exposure than males, especially in regards to behavioral dysfunctions 
(Kelly et al., 1988; Grant et al., 1983). Kelly et al. (1988) demonstrated that spatial 
navigation was selectively impaired in females during a Morris water maze task. Females 
also are typically more active in the Open Field Test than males (Blizard, Lippman, & 
Chen, 1975). The open field test is highly relevant to ADHD literature as it assesses 
hyperactivity with locomotor behaviors as well as well as general levels of anxiety. 
Hyperactivity in rat pups exposed to alcohol in utero corresponds with human clinical 
literature (Riley, 1990). Several studies have assessed hyperactivity patterns in rat 
models of FASD with mixed results. Melcer et al. (1994) demonstrated that males and 
females exposed to high doses of alcohol during postnatal days 4-9 exhibited 
hyperactivity by postnatal day 18. In contrast, Grant, Choi, and Samson (1983) 
demonstrated that male rats exposed to ethanol demonstrated no behavioral 
differences in open field activity. However, female rats neonatally exposed to ethanol 
demonstrated more hyperactivity than female controls. This suggests that females may 
be more behaviorally sensitive to the teratogenic effects of alcohol. Consequently, the 
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current study focused on the effects of alcohol exposure on female rats in the open field 
test as a model of an early precursor of attention deficits – hyperactivity. 
1.5 LINKING THE CATECHOLAMINES IN FASD TO ATTENTION DEFICITS 
Attentional processes are intimately linked with the catecholamine 
neurotransmitters. Catecholamines are a subdivision of monoamine neurotransmitters 
that consist of a catechol nucleus (i.e. a benzene ring with two hydroxyl groups) and an 
amine side chain (i.e. NH2) (Horn, 1973). Within the catecholamine group, dopamine 
and norepinephrine are particularly essential for regulation and modulation of attention 
networks (Clark & Noudoost, 2014). These two neurotransmitters work in tandem with 
subcortical and cortical networks to mediate various aspects of attention and 
hyperactivity. Some evidence suggests that selective lesions of these neurotransmitter 
systems impair attentional processes as severely as surgical ablation of the cortex 
(Brozoski et al., 1979). In FASD populations, hypofunctioning of catecholamine systems 
may generate similar attention deficits. Conversely, stimulant medications that increase 
synaptic catecholamine levels can enhance attention at low-doses (Berridge et al., 
2006). In FASD populations, stimulant medications may normalize catecholamine levels, 
improving attention and hyperactivity (Figure 1.1). This section will focus on the impact 
of dopamine and norepinephrine on attentional networks in relation to FASD. 
Subsequent sections will then discuss the role of stimulant medications in FASD.  
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1.5.1 DOPAMINE AND ATTENTION NETWORKS IN FASD 
Dopamine (DA) neurons originate from two distinct nuclear groups within the 
brainstem: the ventral tegmental area (VTA) and the substantia nigra (SN) (Swanson, 
1982). Neurons in the ventral tegmental area project to the nucleus accumbens (NAcc) 
and the prefrontal cortex, making up the mesolimbic and mesocortical pathways, 
respectively (Swanson, 1982). Neurons in the SN innervate the striatum, making up the 
nigrostriatal pathway (Swanson, 1982). Collectively, these pathways mediate a variety of 
functions including attention, working memory, reward salience, motivation, 
movement, and learning (Schultz, 1992; Sawaguchi & Goldman-Rakic, 1991; Wise, 
2004). Deficits in dopamine could mediate a wide range of behavioral deficits seen in 
FASD populations, and the specific deficit may be pathway specific.  
1.5.1A DOPAMINE IN WHOLE BRAIN 
Early models assessing the relationship between dopamine and attention used 6-
hydroxydopamine (6-OHDA) to ablate vast areas of subcortical and cortical 
dopaminergic networks. These lesion studies resulted in broad impairments in cognitive 
performance, including attention. One of the earliest experiments to associate 
dopamine with cognitive performance was performed in 1979 by Brozoski and 
colleagues. In this study, rhesus monkeys depleted of dopamine were tested on a spatial 
delayed alternation performance task. Dopamine-depleted monkeys performed more 
poorly than controls on this task. More importantly, performance was rescued with 
dopamine agonists (e.g. L-DOPA and apomorphine). This experiment was the first to 
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establish a causal link between dopamine and cognitive performance. Additionally, it 
demonstrated that pharmacological manipulations aimed at increasing dopamine in 
dopamine-deficient models can abate cognitive deficits. If dopamine deficiency is an 
underlying cause of attentional deficits in FASD, this suggests that drug treatment aimed 
at augmenting dopaminergic networks may be beneficial. 
Like lesion studies, the earliest examples of dopamine deficiency in fetal alcohol 
models analyzed global dopamine neurochemical profiles from whole brain 
homogenates. These studies used a liquid-diet paradigms of alcohol exposure, which 
have concerns of malnutrition and dosage (Bonthius & West, 1988). Despite these 
concerns, liquid-diet studies provided an important precedent for future studies on the 
interaction between ethanol and developing dopaminergic systems. One of the first 
studies of dopamine content following a dam-fed liquid diet paradigm during pre and 
postnatal development was by Detering and colleagues in 1980. Detering et al. (1980) 
determined that dopamine was significantly reduced in ethanol-treated pups by 21 days 
of age. However, in this study, Detering et al. suggest that the decrease in dopamine 
may be linked to malnutrition rather than alcohol effects because the effect was also 
evident in the isocaloric matched control group. In 1996, Maier et al. reassessed the 
impact of alcohol on dopamine and its metabolites using a binge-drinking paradigm of 
prenatal alcohol exposure (Maier et al., 1996). This paradigm more accurately reflects 
maternal drinking behavior in humans. Maier et al. demonstrated that dopamine and 
one of its metabolites, 3,4-dihydroxyphenylacetic acid (DOPAC), were reduced in whole 
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brain homogenates of ethanol-exposed rat pups following both chronic exposure 
throughout gestation and a single-dose at gestational day 20. 
1.5.1B DOPAMINE IN STRIATAL AND FRONTAL CIRCUITS 
In an attempt to examine brain region-specific changes in dopamine levels, 
Rathbun & Druse (1985) examined dopamine and its metabolites, DOPAC and 
homovanillic acid (HVA), within specific brain homogenates: hypothalamus, cerebellum, 
cortex, brain stem, striatum, and hippocampus. Rathbun & Druse (1985) demonstrated 
that dopamine levels varied by both age and brain region following a prenatal liquid diet 
paradigm of alcohol exposure. Developmentally, DA content increased in the 
hypothalamus and striatum between 19 and 35 days while DOPAC and HVA levels 
decreased in the striatum and increased in the cortex in controls. Across this same 
developmental window, DA and HVA levels decreased in the cortex in ethanol-exposed 
rats. These data provided 3 important pieces of information: 1) ethanol impacts the 
developmental trajectory of dopaminergic systems, and therefore dopamine levels 
cannot be assessed as static constructs, 2) the periadolescent developmental window 
may be an important target for treatment due to the fluctuation in dopaminergic 
networks during this time, and 3) ethanol may have the strongest impact on 
mesocortical dopamine content. 
Druse, Tajuddin, & Connerty (1990) supported the idea that ethanol impacts 
dopaminergic systems in a developmental manner. Druse et al. (1990) examined the 
impact of impact of a liquid ethanol diet during gestation on postnatal development of 
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dopaminergic networks. Results indicate that ethanol severely impacts striatal and 
frontal dopaminergic systems. Striatal dopamine exhibited a transient (44%) deficiency 
during periadolescence. Frontal dopaminergic systems were also impaired in a transient 
developmental manner:  D1 receptors were reduced by 40% at postnatal day 19 but 
normalized by postnatal day 37 in ethanol-exposed rats. Cortical D1 receptors are 
especially important for attentional processing (Vijayraghavan et al., 2007). Stimulation 
of D1 receptors reflects an inverted-U shape on attention with both high and low levels 
of D1 stimulation being associated with poor allocation of attention (Vijayraghavan et 
al., 2007). From a physiological level, low levels of firing of dopaminergic neurons 
enhance spatial tuning, whereas high levels of firing are overwhelming and impair 
processing of spatial stimuli. An analogy is that dopamine modulates levels of “noise” 
within attentional networks (Clark & Noudoost, 2014). Early deficiency in dopaminergic 
systems in FASD may underlie shifts attention profiles in FASD in an age-dependent 
manner. 
Other studies have examined on the dopamine transporter (DAT) and tyrosine 
hydroxylase (TH) as opposed to post-synaptic markers. DAT is the primary means of 
removing dopamine from the synaptic cleft in subcortical circuits, and TH is the rate-
limiting step in dopamine synthesis. TH and DAT provide important information on 
dopamine synthesis and clearance. Barbier et al. (2009) found that perinatal ethanol 
from a liquid diet paradigm decreased striatal levels of DAT. This study is in agreement 
with a study by Szot et al. (1999) which demonstrated that prenatal ethanol exposure 
via a liquid diet paradigm results in a decrease in DAT messenger ribonucleic acid 
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(mRNA) in the SN and VTA in adult male rats. TH mRNA was also decreased in the VTA 
(Szot et al., 1999). Collectively, these data suggest that dopamine synthesis and synaptic 
clearance are hypofunctioning in nigrostriatal and mesolimbocortical circuits in FASD 
models. 
Prenatal ethanol also induces morphological changes in the mesocortical and 
nigrostriatal dopaminergic system. Shetty, Burrows, & Phillips (1993) reviewed the 
effects of the perinatal ethanol exposure in rats on dopaminergic structure in the SN 
using a Golgi-Cox stain. Specifically, Shetty et al. demonstrated that perinatal ethanol 
exposure in rats resulted in smaller and more densely packed dopaminergic somata, 
decreased dendritic arborization, decreased dendritic branch length, and dysmorphic 
development of these dopaminergic neurons. The impact of prenatal alcohol exposure 
on structure, neurochemistry, and morphology of dopamine neurons is consistent with 
the hypothesis of a hypofunctioning dopaminergic system underlying attention deficits 
in FASD. A hypofunctioning dopamine system may underlie symptoms of hyperactivity 
as well as poor reduction of “noise” when attending specific stimuli. 
1.5.1C DOPAMINE IN THE MESOLIMBIC SYSTEM 
Cortical and subcortical dopaminergic pathways interact with each other 
dynamically. Lesion studies have demonstrated that cortical depletion of dopamine is 
paralleled by mesolimbic hyperactivity in dopaminergic neurons, indicating a functional 
link between these two systems (Nieoullon, 2002). In terms of cognitive performance, 
deficits in dopamine-mediated prefrontal cortical function could reflect poor inhibitory 
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control of sensory information and a decreased ability to instigate appropriate motor 
responses (Russell et al., 1995). In conjunction, deficits in dopaminergic function in the 
nucleus accumbens may distort signals of reward-based stimuli, altering salience values 
and influencing attention to these stimuli (Sonuga-Barke, 2005). In measurements of 
attention, alterations within the mesolimbic system results in reductions in response 
speed and vigor (Robbins & Everitt., 2007).  
FASD models have demonstrated structural and functional deficits in mesolimbic 
dopamine systems. In 1993, Blanchard et al. used in vivo microdialysis to examine 
mesolimbic dopaminergic response to alcohol following prenatal exposure to alcohol 
(Blanchard et al., 1993). Ethanol-exposed rats showed a dopamine response equivalent 
to controls in the nucleus accumbens and striatum following a low dose of alcohol 
administration. At higher doses, males showed the expected increase in dopamine in 
response to alcohol in both structures. However, females showed no reaction in the 
nucleus accumbens and a decrease in dopamine levels in the striatum. These data 
indicate 1) that neurochemical changes in the dopaminergic system following prenatal 
alcohol exposure are both sex and brain-region specific, and 2) that neurochemical 
decrease in dopamine may be more marked in females, further supporting the 
examination of females in the current study. 
Functional differences in stimulus-driven dopamine activity within mesolimbic 
circuits are supported by a series of electrophysiological studies on dopaminergic firing 
patterns (Shen, Hannigan, & Chiodo, 1995; Shen, Hannigan, & Kapatos, 1999). In 1999, 
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Shen, Hannigan, & Kapatos demonstrated that rats exposed to alcohol prenatally via an 
intragastric intubation binge-drinking paradigm had a reduction in spontaneously active 
dopaminergic firing within the mesolimbic circuit. Using tyrosine-hydroxylase based cell 
counts, Shen and colleagues determined that this reduction is not due to dopaminergic 
cell loss, and this reduction is persistent throughout adulthood. This reduction in 
spontaneous firing patterns of DA neurons was only seen in ethanol-treated rats and 
not in intubated controls, indicating that any changes are specific to the ethanol 
treatment and not due the stress from the intubation procedure. 
Collectively, these studies suggest attentional deficits in FASD may reflect 
impairments in different dopaminergic pathways. Interactions between mesolimbic 
input and executive regulation of attention in the prefrontal cortex is of special interest 
in FASD. In FASD populations, hypofunctioning of dopaminergic neurons may result in 
poor tuning of spatial stimuli, thereby impairing attentional modalities such as “shifting” 
of attention. Because stimulant treatments acutely increase striatal and mesolimbic 
dopamine levels, spatial tuning may be normalized following stimulant treatment in 
FASD populations.  
1.5.2 NOREPINEPHRINE AND ATTENTION NETWORKS 
Noradrenergic afferents originate from the locus coeruleus in the brainstem and 
project to various cortical regions where they modulate a variety of functions. In the 
prefrontal cortex, noradrenergic afferents influence attention and vigilance by honing 
neuronal responses to stimuli in attended directions (Rajkowski et al., 2004). Rajkowski 
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et al. (2004) demonstrated that noradrenergic neurons in the locus coeruleus are 
phasically activated in response to target stimuli, and that this response occurs prior to 
any behavioral action, indicating that noradrenergic responses are closely linked to the 
presentation of sensory stimuli. This suggests that attention towards motivationally 
driven targets is modulated by phasic noradrenergic activity from the locus coeruleus. 
Because firing patterns varied with stimuli presentation and behavioral reaction time, 
Rajkowski et al. postulated that norepinephrine (NE) is an important facilitator of 
behavioral responses to attended stimuli by rapidly reorganizing neural networks in 
response to sensory stimuli. In other words, phasic firing of noradrenergic neurons 
allows adaptation to the changing environment that is imperative to selective 
attentional processes. 
Like DA, the relationship between NE and attention exhibits an inverse-U shape 
(Figure 1.1) where low and high NE is associated with impaired attentional states 
(Arnsten & Pliszka, 2011). In relation to FASD populations, low levels of NE in the 
prefrontal cortex may be associated with low “signals” for motivationally driven stimuli, 
thereby facilitating inattentive phenotypes of ADHD. Examining markers of 
dopaminergic and noradrenergic neurotransmitter systems within mesolimbic and 
cortical regions may help elucidate some of the underlying mechanisms distinguishing 
attentional profiles in FASD populations. 
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1.5.4 NORADRENERGIC SYSTEMS IN FASD 
 Norepinephrine (NE) is very similar in structure to DA, and in fact, there is some 
overlap in receptor binding between these two catecholamines. Noradrenergic neurons 
use dopamine β-hydroxylase to transform DA into NE. As such, effects on levels of DA 
content could have downstream effects on NE. In addition, because DA works in tandem 
with NE to modulate attention, it is important to understand if ethanol differentially 
affects these neurotransmitter systems.  
Effects of prenatal alcohol exposure on noradrenergic neurons have been mixed. 
Results in animal models appear to be dependent upon windows of exposure to alcohol, 
brain region, alcohol exposure paradigm, and postnatal treatment. Some of the earliest 
work on the impact of ethanol on developing catecholamine systems came from 
Detering and colleagues. Detering et al. (1980) demonstrated that NE levels were 
significantly lower in whole brain regions of rats prenatally or postnatally exposed to 
alcohol. This result was replicated by Sari et al. in 2010. Sari et al. demonstrated that 
ethanol exposure at early embryonic stages (gestational days 7-13) in mice results in a 
reduction in whole-brain concentrations of norepinephrine via liquid chromatography, 
indicating that the effects of alcohol on noradrenergic systems are visible even at the 
earliest developmental windows. 
In contrast, Rudeen & Weinberg (1993) did not find any differences of 
norepinephrine concentrations among liquid-diet ethanol exposed groups compared to 
pair-fed and ad libitum-fed control groups in any brain region during resting behavioral 
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states. Rather, differences between neurotransmitter systems became apparent after 
stressors. Following a single exposure of restraint stress, NE concentrations were 
reduced in the cortex and hypothalamus but elevated in the hippocampus of rats 
exposed to ethanol relative to both control groups. Following chronic restraint stress, 
NE levels were decreased in the cortex of ethanol-exposed rats relative to both control 
groups. Because these effects varied by brain regions, whole brain measures may 
inadequately discern the more complex effects of alcohol on developing systems. 
Rudeen & Weinberg also noted sex differences in response to alcohol exposure: females 
exposed to ethanol exhibited greater reductions in noradrenergic content than males. 
This indicates that females may be especially sensitive to the effects of ethanol on 
noradrenergic transmission. 
Disagreement between Rudeen & Weinberg (1993), Sari et al. (2010), and 
Detering (1980) may be due to differences in exposure and brain region. Although all 
studies used liquid-diet paradigms of alcohol exposure, Detering et al. (1980) examined 
whole brain homogenates whereas Rudeen & Weinberg (1993) partitioned specific brain 
regions. One possibility is that global changes in noreprinephrine levels may be due to 
brain regions not measured by Rudeen & Weinberg. Disagreement between Rudeen & 
Weinberg (1993) and Sari et al. is likely due to time since exposure. Because Sari et al. 
(2010) examined norepinephrine levels after shortly after alcohol exposure, the effects 
from Sari et al. may be transient.  
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Because early studies often focused on liquid-diet paradigms of alcohol exposure 
during prenatal periods, Tran and Kelly (1999) examined the effects of early postnatal 
exposure on neurotransmitter systems using a binge-drinking paradigm. As postnatal 
exposure corresponds with the brain growth spurt, it is a critical period for the 
development of neural systems. Early postnatal alcohol exposure was associated with 
an increased in NE concentrations in the hippocampus. Early postnatal alcohol exposure 
effects were greater for females than males, again indicating that females may be more 
susceptible during this developmental window. In 1999, Tran and Kelly sought to 
connect disjointed literatures with varying exposure timelines. Using high-performance 
liquid chromatography, Tran and Kelly demonstrated that NE levels were increased in 
the hippocampus in both males and females following a three-trimester paradigm of 
alcohol exposure. These data indicate that binge-drinking paradigms during postnatal 
exposure or during all three trimesters will impact norepinephrine levels in a brain-
region and sex-dependent manner. 
For attention, noradrenergic systems within the prefrontal cortex are especially 
critical. Zimmerberg and Brown (1998) examined the effects of prenatal alcohol on 
plasma concentrations of NE in the prefrontal cortex using a liquid diet paradigm of 
prenatal exposure. Results indicate that NE is decreased in the prefrontal cortex 
compared to chow-fed controls, but an increase in NE compared to pair-fed controls. 
There was no effect of alcohol on NE levels in the NAcc or striatum. Like previous 
results, these data indicate that alcohol exposure impacts catecholamine levels in a 
brain-region-dependent manner and that certain brain regions may be more vulnerable 
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to the effects of alcohol exposure than others. Because noreprinephrine is important for 
enhancing relevant signals within the prefrontal cortex during attention tasks, 
decreased norepinephrine levels in this brain region in FASD models may be responsible 
for inattentive behaviors in FASD populations. 
1.6 TREATING ATTENTION DEFICITS: AN EXAMINATION OF STIMULANT MEDICATIONS 
Stimulant medications are the most common and effective treatment for 
attention deficits. Stimulants comprise a class of psychoactive drugs that augment 
neural activity, increasing mood, awareness, and alertness. Two primary stimulants are 
methylphenidate (Ritalin) and d-amphetamine (Adderall). Although both 
methylphenidate and amphetamine increase monoamine levels, their mechanisms of 
action are distinct. Methylphenidate is part of a class of monoamine blockers whereas 
amphetamine is a monoamine releaser. Blockers obstruct the catecholamine 
transporters DAT, the noradrenergic transporter (NET), and the serotonin transporter 
(5-HTT). These transporters are important regulators of extracellular monoamine levels. 
They bind DA, NE, and serotonin (5-HT) in order to remove them from the synaptic cleft 
and transport them back into the cytosol of the presynaptic neuron. Blocking this 
mechanism acutely increases synaptic levels of DA, NE, and 5-HT for postsynaptic 
receptor binding, resulting in augmented signaling. Because methylphenidate inhibits 
monoamine reuptake after release, its efficacy is dependent upon classic action-
potential driven release from vesicular pools. 
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Unlike methylphenidate, amphetamine is a releasing agent. Therefore, 
amphetamine is not dependent upon classic action-potential mediated release. Instead, 
amphetamine acutely reverses the directional functioning of transporters. This includes 
DAT, NET, 5-HTT, and an intracellular transporter known as the vesicular monoamine 
transporter-2 (VMAT-2). VMAT-2 transports monoamines from the cytosol into synaptic 
vesicles where they await action-potential mediated synaptic release (Riddle, 
Fleckenstein, & Hanson, 2005). These vesicular transporters are dynamic regulators of 
vesicular load, where their functional effects have direct influences on how much 
neurotransmitter is released during synaptic transmission (Eiden, 2000). Amphetamine 
reverses VMAT-2 by disrupting the vesicular pH gradient. As a result, monoamines that 
are packaged into synaptic vesicles are re-released into the cytosol (Sulzer & Rayport, 
1990; Sulzer et al., 1995). Because amphetamine also reverses membrane-bound 
transporters (i.e. DAT, NET, 5-HTT) by initiating an inward-facing conformation change, 
the cytosolic monoamines bind to the now-inward facing transporters and are reverse-
transported into the synaptic cleft (Chen et al., 2010). This results in the force-released 
mechanism of monoamines. Therefore, a critical difference between methylphenidate 
and amphetamine is that methylphenidate efficacy is dependent upon tonic release of 
dopamine while amphetamine is not (Fleckenstein et al., 2007).  
As a result, amphetamine has a much greater effect on extracellular DA, NE, and 
5-HT levels than methylphenidate. Using microdialysis, Kuczenski & Segal (1997) 
demonstrated that a 10 mg/kg dose of methylphenidate increases extracellular DA 
levels in the caudate/ putamen to a concentration of 100 nM whereas a 2.5 mg/kg dose 
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of amphetamine increased DA to nearly 500 nM with peak effects at 30 minutes after a 
subcutaneous injection. Hippocampal levels of NE also significantly increased with 
amphetamine relative to methylphenidate. 5-HT levels were also more impacted by 
amphetamine than methylphenidate. However, both drugs exhibited the greatest 
impact of extracellular levels of DA. 
 Although both methylphenidate and amphetamine increase synaptic levels of 
monoamines through similar mechanisms, children diagnosed with FASD+ADHD and 
ADHD without FASD comorbidity respond differently to these treatments (O’Malley, 
2000). Approximately 90% of preschoolers diagnosed with ADHD are prescribed 
methylphenidate (Goldman et al., 1998; Zito et al., 2000). However, evidence suggests 
that children co-diagnosed with FASD and ADHD have a more positive clinical reaction 
to amphetamine (O’Malley, 2000). O’Malley conducted a pilot study of 30 patients with 
ADHD and FASD. These patients received treatment with either amphetamine or 
methylphenidate. Nineteen of the 30 patients responded positively to amphetamine 
whereas only 5 responded well to methylphenidate. In addition, 8 patients who were 
treated with methylphenidate had negative responses and had to be switched to 
amphetamine; these patients responded positively to amphetamine. Only one patient 
responded preferentially to methylphenidate over amphetamine, and 3 patients 
responded poorly to both methylphenidate and amphetamine. These results indicate an 
increased efficacy for amphetamine treatment compared to methylphenidate treatment 
in FASD clinical populations. 
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Other results on stimulant intervention for attention deficits in FASD are mixed. 
Oesterheld et al. (1998) examined the effectiveness of methylphenidate in Native 
American Children with FASD. FASD children were randomly assigned methylphenidate 
or a placebo for 5 consecutive days. Although methylphenidate significantly improved 
hyperactivity, attention scores were not improved. Because this study did not compare 
methylphenidate to amphetamine, it is unclear whether amphetamine would have 
succeeded where methylphenidate failed. 
1.6.2 DEVELOPMENTAL PERSPECTIVES: TREATMENT DURING WINDOWS OF OPPORTUNITY 
The time period for administration of amphetamine is critical to the types of 
effects that are reported. Juvenile response to pharmacological treatments can be quite 
different from the adult response. For example, juveniles have a decreased sensitivity to 
the locomotor effects of stimulants. This is reflective of fluctuating changes in the 
dopamine transporter during this period. Neurological systems in flux may react 
differently to pharmacological interventions. In adult animals, drug exposure is followed 
by a biological compensatory reaction that counteracts the pharmacologically induced 
state. This process is known as the opponent process. However, when neural systems 
are still maturing, such as during the juvenile developmental window, pharmacological 
effects can induce permanent neurodevelopmental changes that persist long after the 
drug administration has been ceased (Andersen, 2004). This process is known as 
neuronal imprinting. Neuronal imprinting has exciting implications for pharmacological 
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treatments. Pharmacotherapy targeted during specific developmental windows may 
provide an opportunity to shape and normalize aberrant developmental trajectories. 
In support of this theory, Choong & Shen (1999) demonstrated a reduction in 
dopaminergic firing in the VTA following a prenatal paradigm of alcohol exposure. This 
reduction of dopaminergic firing is not evident until four weeks of age and then persists 
into adulthood. This suggests the possibility that early intervention paradigms that 
target the transition period in firing patterns may be effective at shaping developmental 
trajectories in FASD populations. 
1.7 JUSTIFICATION OF STUDY 
 Noradrenergic and dopaminergic systems both play important and diverse roles 
in attention. Both systems have been demonstrated to have deficits in FASD 
populations, and the patterns of these deficits may reflect specific profiles of attention 
deficits. Although each system has been assessed independently in the literature, 
studying NE and DA congruently will provide a more holistic picture of attention 
systems. There is some conflicting evidence on deficits in NE. This may be reflective of 
variations in patterns of exposure. The current study proposes to use a third-trimester 
model of exposure to isolate ethanol’s teratogenicity during the brain’s growth spurt. 
This controlled paradigm will provide valuable additional information on the impact of 
alcohol on developing neural networks. 
 Because catecholamine systems continue developing throughout adolescence, 
extending studies across this developmental window is important for translation into 
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clinical FASD literature. Rat models of FASD have suggested that hypofunctioning of 
catecholamine systems may adversely impact developmental trajectories. Because 
amphetamine directly increases synaptic NE and DA levels, amphetamine may rectify 
this trajectory if administered during appropriate developmental windows. However, 
neurotransmitter systems are still maturing throughout adolescence. This complicates 
clinical understanding of the impact of chronic pharmacological treatments. 
Understanding the impact of chronic amphetamine treatment in FASD populations 
during the periadolescent developmental window will inform treatment paradigms in 
clinical populations of FASD. Therefore, the current study addresses chronic 
periadolescent amphetamine exposure in a rat model of FASD. 
 Lastly, rat models suggest that females may be more sensitive to the teratogenic 
effects of ethanol, displaying greater hyperactivity than males. However, females are 
often underrepresented in the animal literature. This study will therefore focus on the 
impact of ethanol on female hyperactivity. Because hyperactivity is an early precursor to 
more complex attentional deficits, locomotor behaviors will be assessed in an Open 
Field Test at multiple developmental time points across periadolescent development. 
These aforementioned pieces of information have been inadequately addressed 
in the current literature. Therefore, the current study had three aims: 1) to investigate 
the effects of neonatal ethanol exposure on DAT and TH in the NAcc, 2) to investigate 
the effects of neonatal ethanol exposure on DBH in the prefrontal cortex, and 3) to 
investigate the effects of chronic therapeutic doses of amphetamine treatment on DAT, 
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TH, and DBH in the NAcc and PFC during a critical developmental window in a rat model 
of FASD in females. 
 It was hypothesized that DAT, TH and DBH would be decreased in ethanol-
treated rats compared to controls. Chronic exposure to amphetamine was hypothesized 
to increase these markers in all groups. These changes were hypothesized to be 
reflected in behavioral measures of hyperactivity: amphetamine treatment was 
hypothesized to interact with neonatal treatment so that amphetamine reduces 
hyperactive locomotor responses in ethanol-treated rats and exacerbates locomotor 
responses in controls.  
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Table 1.1  
 
Comparison of human and rat developmental periods. 
 
 
Human Rat 
First Trimester Gestational days 1-10 
Second Trimester Gestational Days 11-22 
Third Trimester Postnatal Days (PD) 1-10 
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Figure 1.1. Attentional Performance as an Inverted-U. Low or high levels of 
DA/ NE result in impairments in attention. FASD is associated with 
hypofunctioning of DA/NE systems and impaired attentional performance. 
Amphetamine may improve attention in FASD populations by optimally 
increasing catecholamine levels. 
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CHAPTER 2 
METHODS 
2.1 DOSE-RESPONSE STUDY 
 This study had four levels of amphetamine treatment measured across a 
repeated measure of day (PD 26 to 40). See Figure 2.1 for a timeline. 
2.1.1 ANIMALS 
Twenty-eight juvenile female Long-Evans rats were obtained at postnatal day 23 
(PD 23) with day of birth counted as PD 1. Thirty-two rats were pair-housed in standard 
polypropylene cages at the University of South Carolina School of Medicine’s animal 
facility with ad libitum access to both standard food and water. Cages were changed 
twice weekly with new bedding, fresh water, and additional food. The facility was 
temperature controlled at 22°C and runs on a 12/12 h light-dark cycle with the light 
cycle beginning at 07:00 h. Rats were handled and weighed daily (09:00 h) in order to 
keep track of any effects on body weight effects due to the amphetamine treatment as 
well as to accurate daily treatment dosages. These housing procedures were in 
accordance to all guidelines and regulations by the University of South Carolina’s Animal 
Care and Use Committee.
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2.1.2 AMPHETAMINE TREATMENT 
Each rat was randomly assigned to one of four treatment groups: water (H2O), 
0.5 
mg/kg/day d-amphetamine, 1 mg/kg/day d-amphetamine, and 2 mg/kg/day d-
amphetamine (Sigman, amphetamine HCl). Each group had a total of eight rats. 
Amphetamine doses were calculated based on the salt form of d-amphetamine. The 
range of doses were set to accommodate for the full range spanning from doses 
typically used in children (up to .6 mg/kg/day) (Wolraich & Shubiner, 2009) with the 
higher dosages (up to 2 mg/kg/day) tested in the animal literature (Koffarnus & Katz, 
2010; Bizot, David, & Trovero, 2011). 
D-amphetamine was obtained from Sigma Aldrich (catalog number A5880-5G). 
Solutions were prepared by dissolving with d-amphetamine in distilled H2O for a volume 
of 1 mL/kg. The rats were injected subcutaneously twice a day at 10:30 h and again at 
16:30 h in order to compensate for the short, 1 hour plasma half-life of d-amphetamine 
in juvenile rats (Heijtz, Kolb, & Forssberg, 2003) compared to the longer, 4-6 hour half-
life noted in children (Wolraich & Shubiner, 2009). Each injection was half of the total 
daily dose for the designated treatment condition. Treatment lasted a total of 14 days, 
beginning at PD 26 and culminating PD 40.  
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2.1.3 BEHAVIORAL MEASUREMENTS 
The rats were given an Open Field Test twice during the treatment paradigm to 
assess motor hyperactivity. The first test was conducted on day PD 26, 30 minutes after 
amphetamine treatment on the first day in order to discern baseline levels of activity 
following acute drug administration. Timing was set in accordance with peak 
amphetamine-induced dopamine efflux in the NAcc as determined by Schiffer et al. 
(2006). The second test was conducted on PD 40, 30 minutes after the last treatment. 
Each rat was transported to the behavioral testing room in an opaque transport cage 
immediately prior to testing and then placed in a square 60 x 60 x 35 cm, gray Plexiglas 
chamber for a total of 15 minutes. The floor of the chamber was divided into an inner 
and an outer section, and an overhead video camera recorded the rat’s movements. 
Lighting averaged 400 lux. 
Total distance traveled and proportions of time spent in inner versus outer zones 
were analyzed using Ethovision 7 (Noldus). Total distance traveled is the summation of 
distance traveled in centimeters over the entire testing period. The inner zone was a 
30×30 cm square zone defined as all areas medial to the perimeter (Figure 2.2). After 
the testing procedure, the rat was returned to its cage. Between each test, the chamber 
was wiped down with 5% ammonium hydroxide. 
There are two major locomotor considerations due to the time course of this 
study. The first is the normal developmental changes of locomotor behavior over time. 
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The second is the potential of locomotor sensitization from chronic amphetamine 
treatment.   
2.1.4 STATISTICAL ANALYSES 
Body weights were tracked throughout the experimental procedure as a 
decreased body weight is a potentially adverse side-effect to chronic amphetamine 
treatment. These data were analyzed by a repeated measures ANOVA with the factors 
of day and treatment. Results for the Open Field Test were analyzed as a repeated 
measures ANOVA. The four levels of treatment are as follows: H2O, 0.5 mg/kg AMPH, 1 
mg/kg AMPH, 2 mg/kg AMPH. The repeated measures are the two levels of the factor 
day (acute, chronic). For all data, outliers were replaced with mean values. Outliers were 
defined as any value that is either above or below 2 standard deviations from the mean. 
There were no outliers for the dose-response study. Due to a fire alarm interruption on PD 
26, two rats were removed from analyses. One rat was from the medium amphetamine 
dose group and the other was from the high amphetamine dose group. Statistical 
significance was set at α = .05. To explore statistically significant main effects or 
interactions, Tukey’s HSD post hoc tests were run. 
2.2 FASD STUDY 
Experiment 2 was a 2×2×3 between-groups design with 2 levels of drug 
treatment (i.e. H2O, AMPH), 4 levels of day (PD 26, PD 27, PD 40, PD 41) and 3 levels of 
neonatal exposure (i.e. NC, IC, ET). See figure 2.3 for a timeline. 
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2.2.1 ANIMAL PROCEDURES: THE FASD MODEL 
Timed-pregnant dams were ordered and individually housed in standard 
polypropylene cages with ad libitum access to standard food and water. Housing and 
animal maintenance were the same as those in the dose-response study. A total of 68 
pups from each dam were randomly assigned in a split litter design to one of three 
treatment groups: non-intubated controls (NC), intubated controls (IC), or ethanol 
treated (ET). Day of birth for each pup was designated PD 1. The intubation procedure 
consisted of Intramedic PE 10 tubing dipped in corn oil for lubrication purposes that was 
lowered down the pup’s esophagus. Neonatal ethanol exposure lasted from PD 2 until 
PD 10. The NC pups did not receive any intubations in order to control for the 
procedure’s stress factor. IC pups were intubated twice daily without any administration 
of solutions. ET pups received two daily intubations. The first intubation was between 
09:00 h and 11:00 h and consisted of 3.0 g/kg ethanol in 27.8 mL/kg of enriched milk. 
The second intubation was between 11:00 h and 13:00 h and consisted only of the 
enriched milk in order to compensate for any malnutrition due to the lack of feeding 
behaviors following the ethanol administration. 
All pups were weighed and tattooed for identification on PD 7 (Animal 
Identification & Machine Systems, Inc.). The pups remained with their dams until PD 21 
upon which they were weaned and pair-housed with their same sex littermate. As in the 
dose-response study, this study consisted only of females. The male pups from these 
litters were utilized in a different experiment. 
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2.1.2 BLOOD ETHANOL CONCENTRATIONS 
Blood samples were collected from tail bleeds from IC and ET pups on PD 10 two 
hours after the first intubation, which is optimal for assessing maximum BEC levels (Kelly 
& Lawrence, 2008). Blood samples from the IC pups were used to create a standard 
curve of specific BECs: 0, 50, 100, 200, 300, 400, 500, and 600 ng/mL. Blood was 
collected into centrifuge tubes with 190 µL of 0.53 N perchloric acid. 200 µL of 0.30 M 
potassium carbonate was then added to block coagulation. The samples were vortexed, 
placed on iced, and then centrifuged at 4oC for 20 minutes. The supernatant was 
removed and stored at -80oC until the assay was run. BECs were analyzed via an 
enzymatic process using a 96-well plate according to previously established procedures 
by Dudek & Abbott (1984). Samples and standards were run in duplicate with 50 µL of 
sample, 400 µL of 1.86 mM Tris-NAD stock, and 50 µL of alcohol dehydrogenase added 
to each well. The plate was briefly mixed on an orbital shaker and then incubated for 
one hour prior to absorbance reading (340 nm). BEC values were interpolated from the 
standard’s values.  
2.2.3 AMPHETAMINE TREATMENT 
 Amphetamine treatment was conducted as described in the dose-response 
experiment using the middle dose (1 mg/kg/day) as determined by the results from that 
study. In this study there were two levels of treatment factor: H2O control versus 
amphetamine.  
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2.2.4 BEHAVIORAL ANALYSIS 
 Locomotor behavior was assessed with all 68 animals at four times in this study: 
PD 26, PD 27, PD 40, PD 41. Procedures are identical to the dose-response experiment 
with the test performed 30 minutes following the last d-amphetamine injection.  
 Two behaviors were measured in addition to locomotor activity as described in 
the dose-response study: rearing, grooming. Rearing behavior is defined as both front 
paws lifted simultaneously from the floor. This is used as a basic assessment of motor 
stereotypy (Creese & Iversen, 1973). Grooming behavior can be an index of anxiety 
(Dunn et al., 1987). Grooming was defined as cleaning of the paws or body. All tests 
were analyzed blindly by the same experimenter, Victoria Macht, who has significant 
history analyzing behavioral data. Forty-five videos were randomly selected to be 
analyzed for rearing and grooming behaviors. 
2.2.5 TISSUE PREPARATION AND ANALYSIS 
Twenty-four hours after the last behavioral testing, the rats were anesthetized 
with isoflurane in a bell jar and subsequently perfused with 0.9% saline followed by 
~300mL of a double-filtered 4% paraformaldehyde in 0.1 M phosphate buffered 
solution, pH 7.4. Following decapitation, the brains were removed and post-fixed in the 
4% paraformaldehyde for 24 hours. Then the brains were placed in a 30% sucrose/0.1 M 
phosphate buffered solution where they incubated for 48-72 hours at 4°C until they 
sank. After sinking, they were transferred to cryoprotecting solution and then sliced on 
a freezing microtome at a thickness of 40 µm into coronal sections. Tissue from two 
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targets were separated during sectioning: the NAcc and the medial PFC. The NAcc was 
defined anatomically by plates 10-15 from Paxinos and Watson’s (1998) rat brain atlas; 
the medial PFC was defined anatomically by plates 8-10. Sections were collected serially 
into four separate tubes and then tested for TH, DAT, and DBH content via 
immunohistochemistry. TH and DAT immunohistochemistry was performed on tissue 
from the NAcc; DBH immunohistochemistry was performed on tissue from the medial 
PFC (Figure 2.4). Tissue from 43 rats was analyzed for DBH, tissue from 31 rats was 
analyzed for DAT, and tissue from 35 rats was analyzed for TH. 
Immunohistochemical procedures were performed at room temperature (~25°C) 
unless otherwise specified. Each section was washed in Tris-buffered saline (0.1 M Tris-
HCL with 0.9% NaCl, pH 7.4) and then rinsed with methanolic peroxide to block the 
endogenous peroxidase enzymes in the tissue. Next, the sections were blocked against 
nonspecific staining and the membranes were permeabilized by incubating for 30-60 
minutes in a solution of 0.3% Triton X-100 (TX), Tris-buffered saline (TBS), and 2% 
normal goat serum (NGS).  
The primary antibody for TH was a rabbit anti-tyrosine-hydroxylase IgG 
polyclonal antibody from Millipore. Tissue was incubated in the primary antibody for 24 
hours at a 1:5000 dilution at room temperature and then another 48 hours in the cold 
room (4°C). Following the primary incubation, the tissue was rinsed in TBS and 
incubated with a biotinylated donkey anti-rabbit IgG (1:1000) from Vector Laboratories, 
Inc. for 1.5 hours at room temperature. Next, the tissue was re-rinsed in TBS and 
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incubated for one hour in peroxidase-conjugated streptavidin (1:1600). Finally, the 
tissue was rinsed in TBS, developed in a 0.05%, 3,3’ diaminobenzidine-HCl with Nickel 
Chloride in TBS for 12 minutes, and then mounted on 0.3% gelatin-coated slides. Slides 
were subsequently dried and dehydrated prior to cover-slipping. 
DAT was measured using the same immunohistochemical procedure as TH. The 
primary antibody was the DAT1 monoclonal rat anti-DAT IgG (1:1000) from Millipore. 
The secondary antibody was a biotintylated horse anti-rat IgG (1:1000) from Vector 
Laboratories, Inc. The tertiary remains peroxidase-conjugated streptavidin (1:1600). 
DBH was also measured using the same immunohistochemical procedure as 
described above. The primary antibody was a monoclonal mouse-anti-dopamine-beta-
hydroxylase (1:3000). The secondary antibody was a biotintylated horse anti-mouse IgG 
(1:1000) from Vector Laboratories, Inc. The tertiary remains peroxidase-conjugated 
streptavidin (1:1600).  
2.2.6 IMAGE J ANALYSIS 
Each slide was observed under a light microscope with a digital camera 
attachment. Pictures were saved as a TIFF file and processed in Image J, a free software 
program from NIH (http://rsb.info.nih.gov/ij). The NAcc was identified on sections from 
plate 12 as the area medial and adjacent to the anterior commissure. Images from the 
NAcc were taken at a 20X magnification. The medial PFC was identified as the area 
medial to the white matter from the corpus callosum. Images targeted neuronal layer 
II/III, and these images were taken at a 10X magnification. A minimum of two images 
  
45 
per section were processed. For all data, results were averaged so that only one data 
point was attributed to each animal. Within each picture, immunoreactivity for TH and 
DAT were assessed as average gray values using optical density via ImageJ. Each image 
was 1392 ×1040 pixels which corresponds to approximately 0.64×0.48 mm at 10X 
magnification and 0.32×0.24 mm at 20X magnification, respectively. Immunoreactivity 
for DBH was assessed using a dichromatization method as described by Iritani et al. 
(2010). With this method, an index of immunoreactivity is calculated automatically as 
pixel units within the defined area (Figure 2.5). 
2.2.7 STATISTICAL ANALYSIS 
Results for the Open Field Test were analysis as a repeated measures ANOVA 
(RMANOVA). There were two independent variables: exposure, treatment. Exposure 
refers to the three levels of neonatal exposure: NC, IC, ET. The two levels of treatment 
are H2O and AMPH. There are also four levels of time (i.e. PD 26, PD 27, PD 40, and PD 41). 
Four dependent variables were assessed: total distance traveled, time spent in the inner 
zone, rearing, and grooming. Immunohistological data were assessed by 2x3 ANOVAs. The 
dependent variables in this case were DAT, TH, and DBH.  
For all data, statistical significance was set at α = .05. Outliers were replaced with 
mean values. Outliers were defined as any value that is either above or below 2 standard 
deviations from the mean. There were two outlying data points for total distance traveled in 
the Open Field Test. On PD 26, one rat from the NC-amphetamine group was identified as 
an outlier and replaced with a group mean value for that date. On PD 27, one rat from the 
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IC-water group was identified as an outlier and replaced with the group mean value for that 
date. For time spent in the inner zone, there were five total outliers. One was from a NC-
amphetamine on PD 40, 1 from an IC-amphetamine on PD 26, 1 from an IC-amphetamine 
on PD 41, and 1 from the ET-amphetamine on PD 40 and 41. Following statistically 
significant main effects or interactions, Tukey’s HSD post hoc tests or simple effects tests 
were run as appropriate.
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Figure 2.1. Timeline for Dose-Response Study.  
  
48 
 
 
  
 
Figure 2.2. Open Field Test Apparatus.This Figure depicts the square, plexiglass 
chamber used in the Open Field Test. Inner versus outer zones were measured 
accordingly. 
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Figure 2.3. Timeline for the FASD study. 
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Figure 2.4. Targets from coronal sections. The top target is the NAcc. The 
bottom target is the medial PFC.  
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Figure 2.5.A. DBH staining in medial prefrontal cortex. B. ImageJ 
dichromatization of DBH staining. Analysis is expressed as total immunopositive 
pixels. 
B A 
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CHAPTER 3 
RESULTS 
3.1 DOSE-RESPONSE STUDY  
This study examined the acute and chronic dose-response effects of therapeutic 
doses of amphetamine treatment across the periadolescent developmental window. 
3.1.1 BODY WEIGHTS 
 A repeated measures ANOVA revealed no interaction between day and drug 
treatment, F(3, 14)=1.26, p > 0.05, nor was there a main effect of drug treatment on 
body weight, F(3, 14) = 0.410, p > 0.05. Body weight was significantly impacted by day 
which was expected across development, F(3, 14)=179.61, p < 0.05. As day increased, so 
did body weight. This indicated that all animals grew appropriately, and amphetamine 
treatment did not result in attrition which is a potential negative side effect with higher 
doses of stimulants. These results are summarized in Table 3.1. 
3.1.2 BEHAVIORAL MEASURES 
 A repeated-measures ANOVA demonstrated that total distance traveled 
exhibited a main effect of day, F(1, 26)=38.34, a main effect of treatment, F(3, 
26)=22.92, and a day*treatment interaction, F(3, 26)=4.85, p < 0.05. Tests for simple 
effects revealed that on the first day of testing, rats given medium (1.0 mg/kg/day) and 
high (2 mg/kg/day) doses of amphetamine moved significantly more than rats given
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 water or a low (0.5 mg/kg/day) dose of amphetamine, p < 0.05. At the last day of 
testing, all doses of amphetamine significantly increased locomotion over water, p < 
0.05. This indicates that locomotor effects of amphetamine were sensitized over time. 
However, there was no difference between rats given the medium and high doses of 
amphetamine on the last day of testing, p > 0.05. In summary, the low dose of 
amphetamine was not sufficient to induce a change in locomotion acutely, and there 
was no difference between the medium and high dose. These data are summarized in 
Figure 3.1.  
 Time spent in the inner zone demonstrated a main effect of treatment, F(3, 
26)=5.44, p < 0.05. Post-hoc tests revealed that a medium or high dose of amphetamine 
significantly increased time spent in the inner zone when compared to water treatment, 
p < 0.05. In addition, while 1.0 mg/kg/day amphetamine significantly increased time 
spent in the inner zone when compared to 0.5 mg/kg/day amphetamine, p < 0.05, mean 
time spent in the inner zone decreased in the 2.0 mg/dg/day amphetamine group. 
Therefore 2.0 mg/kg/day amphetamine was not significantly different from either the 
0.5 mg/kg/day dose or the 1 mg/kg/day dose, p > 0.05. Anxious rats have a tendency to 
remain close to the walls and explore the peripheral zone in an open field test, a 
behavior termed thigmotaxis. Decreased thigmotaxis with the 1 mg/kg/day dose of 
amphetamine can be indicative of decreased anxiety at this dose. There was also a main 
effect of day, F(3, 26)=4.64, p < 0.05, but no day*treatment interaction, p > 0.05. Time 
spent in the inner zone increased from acute (PD 26) to chronic (PD 40) time points, 
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indicating an effect of age on exploratory behavior. These results are summarized in 
Table 3.2. 
The medium dose of amphetamine was selected for use in the FASD study for 
two reasons: 1) this dose resulted in both the greatest acute effects as well as the 
greatest sensitization of behavioral effects over time, and 2) the high dose of 
amphetamine exhibited significantly higher measures on anxiety than the medium dose. 
3.2 FASD STUDY 
This study examined the effect of amphetamine treatment across the 
periadolescent developmental window using a model of FASD. This study used the 
medium dose of amphetamine, as determined by the results in the dose-response 
study. 
3.2.1 BECS & BODY WEIGHTS 
BECs for ethanol-exposed animals were 418.8±87.4 (SEM). Body weight 
significantly increased from PD 2 to PD 10, which is expected during development, F(8, 
35) = 939.47, p < .05. Ethanol treatment did not significantly impact body weight in 
neonatal rats, F(2, 27) = 0.41, p > 0.05. This indicates than any group differences with 
ethanol treatment are not due to malnutrition. These data are summarized in Table 3.3. 
There was no main effect of amphetamine on body weight, F(1, 35) = 0.04, p 
>0.05. Neither was there an interaction between amphetamine and neonatal ethanol 
exposure, F(2, 35) = 0.60, p > .05. This indicates that amphetamine did not induce 
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weight loss in these groups, and ethanol treated rats were not more sensitive to weight 
loss effects of amphetamine than controls. These data are also summarized in Table 3.3.   
3.2.2 BEHAVIORAL MEASURES 
Analyses of total distance traveled revealed two main effects and an interaction. 
There was a main effect of day, F(3, 49) = 17.59, p < .05, and drug treatment, F(1, 51) = 
95.87, p < 0.05. There was also a significant day*treatment interaction, F(3, 49) = 6.60, p 
< 0.05. Analyses of simple main effects revealed that within the amphetamine 
treatment group, total distance traveled significantly increased an average of 
2096.19±475.79 cm from PD 26 to PD 27, p < 0.05, an average of 2890.82±504.75 cm 
from PD 26 to PD 40, p < 0.05, an average of 3881.48±474.44 from PD 26 to PD 41, p < 
0.05, an average of 1785.29±474.44 from PD 27 to PD 41, p < 0.05, and average of 
990.66±331.70 cm from PD 40 to PD 41, p < 0.05. These data are represented as mean ± 
SEM. Total distance traveled did not significantly increase across any days in the water 
treatment groups. These results indicate that amphetamine induced hyperactivity 
acutely and that rats became sensitized to the locomotor effects of amphetamine 
chronically, irrespective of neonatal ethanol exposure condition. These results are 
summarized in Figure 3.2.  
Analyses of time spent in the inner zone revealed a main effect of day, F(3, 51) = 
8.39,  treatment, F(1, 53) = 41.22, and a day*treatment interaction, F(3, 51) = 12.75, p < 
0.05. Analyses of simple main effects revealed that within the amphetamine treatment 
condition, time spent in the inner zone increased an average of 31.41±7.23 seconds 
from PD 26 to PD 27, p < 0.05, an average of 42.06±5.1 seconds from PD 26 to PD 40, p < 
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0.05, and an average of 42.41±6.01 seconds from PD 26 to PD 41 p < 0.05. Time spent in 
the inner zone did not change within water treatment groups. These data are 
represented as mean ± SEM with results summarized in Figure 3.3. 
Rearing behaviors were also analyzed as a measure of stereotypy.  Rearing 
behaviors exhibited a main effect of day, F(3, 37) = 6.04, p < 0.05, and treatment, F(1, 
39) = 36.75, p < 0.05. Rearing behaviors decreased as day increased when collapsed 
across all conditions (Figure 3.4). Specifically, rearing behaviors decreased from PD 26 to 
PD 40 by an average of 18.71±7.67 counts. As expected, rats receiving amphetamine 
treatment exhibited more rearing behaviors than rats receiving water treatment. These 
data indicate that amphetamine did not differentially induce rearing by treatment 
groups, suggesting that ethanol-exposed groups were not more sensitive to this form of 
stereotypy. 
Grooming exhibited main effects of day, F(3, 36) = 8.51, p < 0.05, and treatment, 
F(1, 38) = 49.91, p < 0.05. Amphetamine significantly reduced grooming behavior from 
an average of 92.70±5.61 seconds±SEM within water treated groups to 38.47±5.59 
seconds±SEM. Grooming behavior also significantly decreased from acute (79.64±5.43) 
to chronic (54.42±5.28) sessions, indicating a developmental impact on grooming 
behavior.  
3.2.3 IMMUNOHISTOCHEMISTRY 
 An omnibus ANOVA revealed no impact of ethanol exposure or amphetamine 
treatment on DAT or TH, p > 0.05.  Data are provided in Table 3.4. 
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There was a significant effect of treatment on DBH staining within the prefrontal 
cortex, F(1, 37) = 27.04, p < 0.05, but no effect on exposure, and no interaction. DBH was 
significantly increased following amphetamine treatment. DBH results and 
representative pictures of staining are displayed in Figure 3.5.
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Table 3.1  
 
Change in Body weights (g) During Amphetamine Treatment  
 
 
Dose-Response Study 
Treatment Change in Body Weight (g) 
H2O 71.16±2.99 
0.5 mg/kg/day AMPH 72.01±1.98 
1 mg/kg/day AMPH 74.86±2.92 
2 mg/kg/day AMPH 74.86±2.92 
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Figure 3.1. Total Distance Traveled in Dose-Response Study. Data are 
represented at both acute (PD 26, 27) and chronic (PD 40, 41) time points. Data 
are expressed as the mean ± SEM. Amphetamine significantly increases total 
distance traveled in a dose response fashion.  Asterisks represent data that is 
significantly different from the water treatment group, p < 0.05. 
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Table 3.2.  
 
Behavioral Data for the Dose-Response Study 
 
 
Treatment Distance Traveled (cm) Time in Inner Zone (sec) 
 Acute Chronic Acute Chronic 
H2O 4332.± .474 4802.± .423 15.± .9 20.± .9 
0.5 mg/kg/day AMPH 5855.± .658 8886.± .1105 24.± .7 54.± .20 
1.0 mg/kg/day AMPH 7887.± .731 13571.± .1170 57.± .16 73.± .13 
2.0 mg/kg/day AMPH 9336.± .544 12569.± .828 34.± .11 67.± .16 
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Table 3.3.  
 
Exposure and Treatment Impact on Body Weights (g) 
 
 
  Non-treated 
Control 
Intubated 
Control 
Ethanol 
Treated 
PD 2-10  11.29±0.37 11.24±0.41 10.56±0.36 
PD 26-40 H2O 70.99±3.07 69.25±2.43 71.20±2.19 
 Amphetamine 66.48±2.76 67.22±1.47 67.44±2.45 
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Figure 3.2. Total distance traveled (cm) in the Open Field Test for the FASD 
Study. Acute testing consists of postnatal days 26 and 27. Chronic testing consists 
of postnatal days 40 and 41. Habituated testing is the second test day during the 
acute and chronic conditions. The data are expressed as the mean ± SEM. 
Asterisks represent data significant from H2O, p < 0.05. Pound symbols represent 
data significant from PD 26. 
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Figure 3.3. Time in Inner Zone in FASD Study. Data represent time spent in 
the inner zone at PD 26, 27, 40, and 41 respectively. Time was evaluated as 
total seconds in inner zone. The data are expressed as the mean ± SEM. 
Asterisks represent data significant from H2O, p < 0.05. Pound symbols 
represent data significant from PD 26. 
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Figure 3.4. Rearing in FASD Study. Counts of rearing are expressed across all 
four Open Field Tests. Ethanol exposure groups have been collapsed. The data 
are expressed as the mean ± SEM. Asterisks represent data significant from 
H2O, p < 0.05. Asterisks represent data significant from H2O, p < 0.05. Pound 
symbols represent data significant from PD 26. 
 
  
65 
 
Table 3.4.  
 
Immunohistological Analysis via Optical Density 
 
 
 
Tyrosine Hydroxylase Dopamine Transporter 
 H2O AMPH H2O AMPH 
ET 2898.± .433 3166.± .320 3371.± .61 3844.± .167 
IC 3092.± .371 3325.± .247 3859.± .189 3943.± .159 
NC 3001.± .361 3298.± .261 3775.± .132 4064.± .122 
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Figure 3.5. A. Immunopositive staining for DBH in the medial prefrontal cortex, 
as analyzed by ImageJ. The data are expressed as the mean ± SEM. B. 
Representative pictures of DBH staining by exposure group and treatment. 
Images represent staining within layers II/III from the medial PFC. 
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CHAPTER 4 
DISCUSSION 
The current studies support previous literature indicating that amphetamine 
increases locomotor activity acutely (Dandiya & Kulkarni, 1974), and that this activity 
becomes sensitized chronically (Lynch, Kennny, & Leonard, 1978). In the dose-response 
study, amphetamine increased total distance traveled acutely, and these effects were 
sensitized over time. Sensitization to amphetamine-induced locomotor hyperactivity 
was replicated in the FASD study. However, contrary to hypotheses, ethanol-treated rats 
did not exhibit any behavioral differences in the open field test, nor did they exhibit any 
differential response to amphetamine. These behavioral findings are paralleled by 
neurochemical data. DBH staining in the medial prefrontal cortex was increased in 
amphetamine treated rats, but there were no differences DBH, DAT, or TH staining in 
any neonatal treatment groups for the FASD paradigm. 
4.1 DOSE-RESPONSE STUDY 
The dose-response study examined the acute and chronic dose-response effect 
of multiple therapeutic doses of amphetamine on locomotor behavior in female rats. In 
accord with previous literature, amphetamine induced a dose-response increase in total 
distance traveled (i.e. locomotor activity) when it is first administered on PD 26.
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 Chronically (PD 40), amphetamine-induced locomotor hyperactivity increased 
further, indicating sensitization. However, there were no significant differences between 
the medium and high doses chronically, suggesting that 1 mg/kg/day of amphetamine is 
sufficient to induced changes in locomotor behavior but that increasing that dose is not 
necessary. 
In addition to increasing locomotor behavior, amphetamine treatment impacted 
time spent in the inner zone both after one administration and chronically. Unlike the 
effect on locomotion, amphetamine did not exhibit a linear dose-response effect on 
time spent in the inner zone. Rather, time spent in the inner zone increased with a 
medium (1 mg/kg/day) but not a not high (2 mg/kg/day) or low dose of amphetamine 
(0.5 mg/kg.day). Although crude, more time spent in the inner zone can be indicative of 
an anxiolytic response as time spent in the inner zone tends to increase with anxiolytic 
drugs (Prut & Belzung, 2003; Wallace et al., 2008). In contrast, wall hugging (i.e. 
thigmotaxis) can be considered an anxiogenic behavior (Wallace et al., 2008). Time 
spent in the inner zone may reflect evolutionary mechanisms modulating necessary risk 
taking in new environments for exploration to find food and mates. Low anxiety and 
high exploration in novel environments are also important during adolescence as these 
behaviors are thought to help develop independence (Spear, 2000). The anxiogenic 
response to higher doses of amphetamine is well-substantiated in the literature (Biala & 
Kruk, 2007; Cancela et al., 2001; Pellow et al., 1985). In contrast, the anxiolytic response 
of the medium dose of amphetamine is not well documented. These results could 
indicate a curvilinear relationship between the pull of environmental exploration and 
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risk-assessment responses from non-specific threats: moderate activation of 
catecholamine networks enhance exploratory behavior but higher activation induces 
anxiogenic responses (Prut & Belzung, 2003). 
Importantly, time spent in the inner zone is not correlated with the distance 
traveled: higher doses of amphetamine resulted in increased distance traveled but 
decreased time spent in the inner zone compared to the medium dose. 
Underdevelopment of the prefrontal-limbic circuits in juveniles may have contributed to 
the medium dose’s interesting effect (Lewis, 1997). 1 mg/kg/day of amphetamine may 
provide optimal activation within the prefrontal cortex without provoking an anxiogenic 
response with over-activation at prefrontal glutamatergic inputs.  
These results suggest two things: 1) a medium dose is sufficient to induce a 
behavioral change in locomotion, and 2) increasing the dose beyond this point is 
unnecessary. Collectively, the dose-response data supported the use of 1mg/kg/day of 
amphetamine for the FASD study. 
4.2 FASD STUDY 
This study examined the impact of a third-trimester binge paradigm of ethanol-
exposure followed by chronic amphetamine administration on behavioral hyperactivity 
and catecholamine networks. Although amphetamine induced several behavioral effects 
and one neurochemical effect, ethanol-exposed animals were not differentially 
impacted on any measures. 
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4.2.2A BEHAVIORAL DATA 
In the FASD study, amphetamine increased distance traveled in all groups. Like 
the dose-response study, this effect on locomotion became sensitized over time. In 
addition, amphetamine increased time spent in the inner zone acutely, and this effect 
became sensitized chronically within the study. This is in agreement with the dose-
response study regarding data on the medium dose but not the high dose of 
amphetamine, indicating that behavioral effects are dose-dependent.  
Two additional behavioral measures were added in the FASD study: rearing and 
grooming. Rearing behaviors were used as a marker of amphetamine-induced 
stereotypy. Unsurprisingly, rats treated with 1 mg/kg/day amphetamine exhibited more 
rearing behaviors than their water-treated counterparts. However, all rats 
demonstrated decreased rearing across each testing day, and there was no interaction 
between amphetamine and testing days on rearing behavior. One explanation is that at 
this dose, amphetamine does not induce sensitization to stereotypy. Alternatively, 
rearing behavior may have decreased over time due to progression to minute, oral 
stereotypies. However, Scholl et al. (2009) demonstrated that even at 6 consecutive 
intraperitoneal injections of 2.5 mg/kg amphetamine, intense oral stereotypies were 
minimal. This suggests that the current dose did not result in sensitization of stereotypy, 
which would have been a negative consequence for a chronic therapeutic dose. 
Unlike rearing, grooming behavior was inversely related to amphetamine 
treatment. Because grooming is sometimes taken as a measure of anxiety, this indicates 
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that amphetamine increased exploratory behavior without increasing anxious behavior 
(Dunn et al., 1987). This parallels that finding that amphetamine increased time spent in 
the inner zone compared to controls. Collectively, these results argue that chronic 
administration of 1 mg/kg/day dose of amphetamine does not have anxiogenic effects. 
In contrast, Cancela et al. (2001) demonstrated that 2 mg/kg intraperitoneal injections 
of amphetamine for 9 consecutive days did induce anxiogenic responses in an elevated 
plus maze. Because the 2 mg/kg/day dose of amphetamine in the current dose-response 
study increased distance traveled but decreased time spent in the inner zone when 
compared to the 1 mg/kg/day dosage, the current study supports the proposal of a 
threshold dose for anxiogenic effects of stimulants. Many studies utilize 2 mg/kg doses 
of amphetamine as equivalent to a therapeutic dose used in humans. The current study 
does not support these results. Rather, these data suggest that doses should not exceed 
1 mg/kg/day in order to avoid negative behavioral and potentially neurological 
consequences.  
Contrary to the hypotheses that ethanol-treated rats would exhibit hyperactivity, 
ethanol-treated rats did not exhibit increases in locomotion nor did they show 
differential responses to amphetamine compared to control rats. Similarly, there were 
no differences among groups with respect to time spent in the inner zone. Generally, 
hyperactivity is the result of either insufficient inhibition of locomotion during 
exploration or deficits in habituation to the environment (Riley, 1990). Associations with 
locomotor hyperactivity have yielded mixed results in animal models. These results 
appear to vary by three factors: age, exposure paradigm, and sex. 
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In regards to age, young rats show enhanced hyperactivity compared to 
adolescent and young-adult rats. An early study by Means et al. (1984) demonstrated 
hyperactivity in male rats exposed to ethanol prenatally via a liquid diet paradigm at 
postnatal day 26. Means et al. (1984) also demonstrated that ethanol-exposed rats were 
hypersensitive to the locomotor-inducing effects of methylphenidate at 100+ days of 
age. Kelly, Hulsether, and West (1987) demonstrated that hyperactivity peaks around 
postnatal day 20 and declines by postnatal day 30. This hyperactivity re-emerges in aged 
rats (Abel &Dintcheff, 1986). These studies suggest that locomotor activity in ethanol-
exposed rats exhibits a curvilinear function. 
Although locomotor hyperactivity is not a direct measure of attention, the 
relationship between locomotor hyperactivity and attention is extremely important in 
FASD. Hyperactivity is frequently reported in children with FASD, although it is replaced 
by attentional deficits during pre-adolescent development (Driscoll et al., 1990). This 
developmental shift between hyperactivity and attention deficits in human studies 
parallels the curvilinear function of hyperactivity demonstrated in animal models. 
Therefore one possibility for the lack of hyperactivity in ethanol-exposed rats is that the 
tested ages (PD 26, 27, 40, and 41) fell within the developmental depression of 
hyperactivity demonstrated in animal models. Comparison with human studies suggests 
that this depression in hyperactivity may be due to developmental shifts toward 
attentional deficits. This possibility necessitates further studies examining attentional 
capacities during this age range. 
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Variation in locomotor activity by age was also reported by Marche, Danel, and 
Bordet (2011). However, in contrast with previous studies, Marche, Danel, and Bordet 
demonstrated decreased locomotion (i.e. hypoactivity) in rats exposed to ethanol 
prenatally at three weeks (~postnatal day 21), increased locomotion (i.e. hyperactivity) 
of those same rats at 5 weeks (~postnatal day 35), and then a return to hypoactivity at 
10 weeks (~postnatal day 70). These effects contradict previous research. One major 
difference between these studies is that Marche, Danel, and Bordet (2010) used a much 
more extensive exposure paradigm. Dams were exposed to alcohol for four weeks 
before breeding, throughout gestation, and then for 3 weeks during lactation. Because 
the last period of exposure extended past the human equivalent of the third trimester 
(Bayer et al., 1993), these data may not generalize to the human condition. However, 
these data do suggest that the relationship of ethanol-exposure on activity can vary 
substantially and potentially be inverted, depending on exposure paradigm.  
The most compelling differences in activity are found in examining sex 
differences. Most studies (Means et al., 1984; Marche, Danel, & Bordet, 2011) 
exclusively examine males whereas the current study examined females. Wilcoxon et al. 
(2005) demonstrated that locomotor activity varies by sex. Using a liquid diet paradigm 
of alcohol exposure, Wilcoxon et al. (2005) demonstrated hypoactivity in females in an 
open field test at postnatal day 100. This decrease in locomotor activity was not evident 
in males. Similarly, Gilbertson and Barron (2005) documented hyperactivity following 
neonatal ethanol exposure during postnatal days 19-21. However, hyperactivity during 
this period was limited to males. Females were not significantly different from controls. 
  
74 
Because males are more commonly used in animal research, the current study supports 
the need to include females in future studies, especially in regards to the developmental 
effects of ethanol. 
In conclusion, hyperactivity is most frequently reported in males during 
preadolescent (PD ~21) and adult (PD 100+) ages following prenatal exposure using 
prenatal exposure and liquid diet paradigms. Because the current study used females 
and a third-trimester exposure paradigm, and because activity was monitored between 
PD 26 and 41, hyperactivity in exploratory behavior may not have been evident. 
An alternative explanation for failure to demonstrate hyperactivity in ethanol-
exposed rats is that hyperactivity was masked by an augmented stress response. Animal 
models of FASD are robustly associated with a hyper-reactive hypothalamic-pituitary-
adrenal axis and behavioral responses to stress (Taylor et al., 1982; Weinberg, 1992; 
Hellemans et al., 2010). This stress-response could also have been elicited due to 
variations in testing conditions between studies. Rats habitually prefer dark or dim-light 
settings (8-13 lux). Bouwknecht et al. (2007) demonstrated that high-light conditions 
(400 lux) in an open field test significantly reduced locomotor activity and increased 
anxiety responses when compared to low-light conditions, indicating that low-light 
conditions reduce anxiety behaviors. Thomas et al. (1998) demonstrated hyperactivity in 
rats neonatally exposed to alcohol, but testing was conducted in dark conditions. 
Similarly, Wilcoxon et al. (2005) demonstrated age and sex effects of a liquid diet 
paradigm of alcohol exposure, but testing conditions were performed at 160 lux. As the 
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current experiment was tested at high-light settings (400 lux), sex and age may have 
also impacted sensitivity to lighting-induced stress effects.  
Weinberg (1992) demonstrated that the stress response, as indicated by 
corticosterone reactivity, of ethanol-treated rats following four-hours of restraint stress 
is greater in females than males. Since the current study used only females, light-
induced stress may have had a greater impact on locomotion than in previous 
experiments. In sum, stress from lighting conditions in the current study could have 
increased anxiogenic behavior which would result in decreased locomotion, masking 
any hyperactivity in ethanol-treated rats.  
The lack of developmental impact of ethanol on rearing behaviors in the current 
study is discordant with previous studies. Using a liquid diet paradigm of ethanol 
exposure, Wilcoxon et al. (2005) demonstrated that rearing behaviors are impacted by 
ethanol exposure in a sex-dependent manner: females reared more than males, but 
females exposed to ethanol reared less than controls. This finding was not replicated in 
the current study. Females exposed to alcohol showed no differences in rearing when 
compared to intubated and non-treated controls across any testing day. This could be 
due to paradigm differences as the current study used a binge-drinking paradigm 
whereas Wilcoxon et al. used a liquid-diet paradigm for FASD. Alternatively, differences 
in ethanol’s impact on rearing behaviors could be due to age-differences. The current 
study tested rats at PD 40 whereas Wilcoxon et al. performed the open field test at PD 
100.The developmental impact of ethanol on rearing may only be noticeable in older 
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rats. This hypothesis is supported by the study by Marche, Danel, & Bordet (2011). 
Marche, Danel, & Bordet (2011) demonstrated that rearing behaviors decrease in an 
age-dependent manner. At 3 weeks of age, ethanol-exposed rats exhibited similar 
rearing behaviors to their controls. However, by 10 weeks of age, ethanol-exposed rats 
reared less than controls. Because the current study only examined rats just over 5 
weeks of age, ethanol’s impact on rearing may have been obscured by the juvenile drive 
for exploration. 
In conclusion, ethanol-treated rats did not exhibit any behavioral differences in 
the open field test. Ethanol-treated rats also did not exhibit any differential response to 
amphetamine. Although multiple studies have suggested that ethanol-treated rats 
should exhibit hyperactivity, failure to replicate this finding could be due to 1) lighting 
conditions in the open field environment, or 2) an attentional task would have been 
more suitable measure considering the developmental age at which the open field tests 
were conducted. The current study did support well established results in the field that 
amphetamine induces locomotion in a dose-response fashion. Importantly, the current 
study supports the idea that in order for animal studies to exhibit human translational 
validity for therapeutic uses of amphetamine, dosages should not exceed 1 mg/kg/day. 
This finding encourages re-evaluation of dosing procedures for future studies in these 
fields. 
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4.2.2B NEUROANATOMICAL DATA 
Although amphetamine mechanistically impacts both dopaminergic and 
noradrenergic neurons, only DBH staining in the prefrontal cortex was impacted by 
amphetamine in the current studies. DBH staining increased in the medial prefrontal 
cortex in rats chronically treated with amphetamine during the periadolescent window, 
meaning that there was an increase in either noradrenergic innervation or synthesis. 
Amphetamine did not impact DAT or TH, nor was there an effect of alcohol treatment 
on any markers. 
An increase in DBH may indicate an increase in innervation by noradrenergic 
axons. Innervation may be due to either 1) amphetamine-induced plasticity of the 
prefrontal cortex during the periadolescent developmental window, or 2) 
amphetamine-induced plasticity that is independent of developmental period. Because 
the adolescent prefrontal cortex is undergoing rapid maturation and reorganization of 
neural networks, drug exposure during this time window can change developmental 
trajectories (Andersen, 2004). The former hypothesis parallels a similar finding by 
Reynolds et al. (2014) that chronic amphetamine treatment during adolescence (PD 22-
31) but not adulthood (PD 75-84) increases dopaminergic innervation in the medial 
prefrontal cortex in mice. Conversely, this increase in innervation was paralleled by a 
reduction of presynaptic sites on dopaminergic axons. Reynolds et al. (2014) suggest 
that drug exposure during adolescence has an increased ability to alter neural networks. 
Unlike the current study, Reynolds et al. (2014) examined dopaminergic and not 
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noradrenergic networks. Reynolds et al. (2014) also used a much larger (4 mg/kg) dose 
of amphetamine as a means of studying adolescent exposure to drugs of abuse. 
However, the same principles apply to the current study: the adolescent window may 
be sensitive to changes in noradrenergic innervation within the medial prefrontal cortex 
following repeated amphetamine exposure.  
Within the medial prefrontal cortex, noradrenergic networks may be more 
sensitive to chronic amphetamine than dopaminergic networks. Berridge and Stalnaker 
(2002) demonstrated that a 0.5 mg/kg subcutaneous injection of amphetamine 
increased extracellular norepinephrine levels 175% above baseline and extracellular 
dopamine levels by only 125% above baseline. Baseline concentrations of DA and NE 
were both approximately at 1 pg/20 uL of cerebral spinal fluid. Amphetamine’s ability to 
preferentially increase extracellular levels of NE in the medial prefrontal cortex may be 
due to anatomical distinctions between DAT and the noradrenergic transporter (NET). 
DAT has higher concentrations and clearance capacity within the infralimbic cortex 
whereas NET has higher concentrations within the medial prefrontal cortex (Heidbreder 
& Groenewegen, 2003). Because amphetamine reverses both DAT and NET to force 
release of presynaptic NE and DA, amphetamine may have a greater impact on 
noradrenergic levels due to increased NET concentration within this region.  
The ability of a therapeutic dose of amphetamine to change developing 
neurocircuitry could have significant behavioral and cognitive effects for adolescents 
using stimulant medication. Within the prefrontal cortex, noradrenergic neurons act as 
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neuromodulators of glutamatergic pyramidal afferents (Ji et al., 2008; Market & 
Aghajanian, 1999; Steketee, 2003). Therefore, changes in noradrenergic innervation 
could have significant impacts on afferent projects of other neurotransmitter systems. 
This, in turn, could impact functions dependent upon the medial prefrontal cortex such 
as arousal, attention, and working memory (Dalley, Cardinal, & Robbins, 2004).  
In addition, noradrenergic release within the prefrontal cortex modulates 
amphetamine-induced hyperactivity (Darracq et al., 1998). Darracq et al. (1998) 
demonstrated that locally administering an α-1 noradrenergic antagonist into the rat 
prefrontal cortex in conjunction with an intraperitoneal injection of 2.0 mg/kg 
amphetamine blocked amphetamine-induced locomotor hyperactivity without 
impacting amphetamine induced dopamine release in the nucleus accumbens. This 
suggests that stimulation of noradrenergic postsynaptic receptors are critical for 
amphetamine’s effect on locomotion. Changes in noradrenergic innervation within the 
prefrontal cortex may partially explain sensitization to locomotion following chronic 
amphetamine administration. This would also explain sensitization to amphetamine-
induced locomotion following chronic treatment in the absence of changes in TH or DAT 
content in the current study. 
Contrary to predictions, neither dopaminergic nor noradrenergic markers varied 
by alcohol exposure. One possibility is that synthesis markers like TH and DBH may be 
resistant to neonatal ethanol exposure. Alternatively, physiological changes in these 
systems may not be reflected in immunohistological measures. The latter is supported 
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by electrophysiological studies by Shen, Hannigan, & Kapatos (1999). Shen et al. (1999) 
demonstrated that mesolimbic dopaminergic neurons had reductions in spontaneous 
firing patterns. However, there were no differences in tyrosine-hydroxylase based cell 
counts. Because the current study also examined TH staining, dopaminergic neurons 
may have exhibited electrophysiological alterations that were not detectable with the 
current methods. 
Although dopamine-beta hydroxylase specifically has not been investigated 
previously, literature regarding noradrenergic content has yielded mixed results. 
Although some of these differences can be explained by variations in alcohol exposure 
paradigms, Rudeen & Weinberg (1993) suggested that even when no baseline 
differences in noradrenergic content are detected, deficiencies in noradrenergic systems 
become evident following stressors. Therefore one explanation of the current data is 
that immunohistological measures did not capture functional differences in ethanol-
mediated effects on noradrenergic neurons. This explanation would be in accord with 
previous studies regarding dopamine which suggests that synthesis enzymes may not be 
good markers for ethanol’s developmental impact on catecholaminergic networks. 
In summary, chronic amphetamine increased noradrenergic innervation within 
the prefrontal cortex, but not dopaminergic markers within the nucleus accumbens. This 
increase in innervation could partially explain sensitization to amphetamine-induced 
locomotor hyperactivity. Ethanol did not impact any neurological measures. This may be 
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due to functional rather than structural differences in catecholaminergic transmitter 
systems. 
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CHAPTER 5 
FUTURE DIRECTIONS 
The current study had many limitations which may have impacted results. These 
limitations pertain to both behavioral measures as well as immunohistological 
measures.  
5.1 LIMITATIONS OF BEHAVIORAL MEASURES 
The greatest limitation of the current study is that attention was not directly 
measured. Rather, hyperactivity was used as a correlation of attentional indexes. 
Human studies have suggested that hyperactivity diminishes during the ages tested in 
this study in favor of attentional deficits (Driscoll et al., 1990). Hence, assessing 
attention directly using a five choice-serial reaction test could provide a more sensitive 
measure of cognitive deficits than the open field test (Robbins, 2002).  
Although the open field test has been used as a measure of locomotor activity 
for decades, examining locomotion in the open field test has many limitations and 
confounding variables (Walsh & Cummins, 1976). Testing conditions, age, sex, 
habituation to the testing chamber, and transport to the testing chamber all impact 
locomotion (Walsh & Cummins, 1976). Because the current study used high-lighting 
conditions, interactions with light-induced stress response and ambulation may have 
confounded ethanol effects. Lighting conditions in an open field test could be lowered
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for future studies, which would hopefully decrease the anxiogenic response to the test. 
Alternatively, using an elevated plus maze in conjunction to an open field chamber 
would help separate anxiolytic behavior from locomotor behavior (Pellow et al., 1985). 
Anxious rats spend more time in the closed arms of an elevated plus maze (Hogg, 1996). 
Variations in time spent in the closed arms could then be used as a covariate for 
locomotor activity, thus separating decreased activity due to anxiety from any 
locomotor hyperactivity evident in the open field.  
An additional limitation of the current study is that both experiments focused on 
effects of alcohol and amphetamine in female rats. Due to the sex differences in 
locomotor activity, development, vulnerability to ethanol-mediated damage, and 
dopaminergic tone, examination of sex differences is an important future measure. 
Success of pharmacological intervention for hyperactivity and attentional deficits may 
be sex-dependent. Therefore, a future direction would be to investigate males and 
females using the proposed measures. 
A final behavioral point would be to investigate whether the potentially 
beneficial effects of chronic amphetamine treatment in hyperactivity and attention 
translate into the social realm in animal models. Deficits in social functioning are a core 
feature of FASD children and provide far-extending repercussions due to the social 
nature of educational development (Thomas et al., 1998). Non-FASD ADHD children that 
have been treated with stimulants show a variety of benefits, including improved social 
skills (Greene et al., 1999). Future studies could examine the impact of early chronic 
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exposure to amphetamine followed by observations of social play. Activity in both the 
striatum and medial prefrontal cortex are integral to the mediation of social play (van 
Kerkhof et al., 2013). Because chronic amphetamine increased noradrenergic 
innervation within the medial prefrontal cortex, these changes could also impact social 
play behavior. 
In sum, more elaborate behavior studies on attentional measures will be useful 
future directions to rectify limitations in the current study. Future studies should include 
both males and females as the current study suggests supports previous literature 
suggesting that females exhibit different behaviors following developmental exposure 
to alcohol than males. 
5.1 LIMITATIONS OF NEUROLOGICAL MEASURES 
Although DBH, DAT, and TH are integral to understanding the chronic effects of 
amphetamine treatment for models of fetal alcohol syndrome, they are only the 
preliminary steps in investigating the dopaminergic and noradrenergic systems with 
regards to influence their influence on attention and hyperactive behavior in FASD. This 
study was selective in examining the dopaminergic markers within the nucleus 
accumbens and noradrenergic markers within the medial prefrontal cortex. In the 
future, dopaminergic and noradrenergic markers should be examined within the same 
brain region to provide a more cohesive picture of network integration. Markers for 
acetylcholine would provide additional support on neural networks for attention as 
acetylcholine is also robustly associated with modulation of attention networks. Post-
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synaptic receptors for dopamine, norepinephrine, and acetylcholine may also provide 
insight as to how enhanced dopaminergic release impacts post-synaptic structure. 
Examination of these postsynaptic markers within the prefrontal cortex is the next step 
in this project. 
Future studies should also assess phosphorylated TH and DBH to examine 
activation of this enzyme rather than quantification of TH and DBH presence in general. 
This presents a general limitation of all of these immunohistological measures: they do 
not represent functional differences, only structural differences. An additional potential 
future step would be to examine DAT, TH and DBH activity using functional assays. A 
microdialysis study would also enable examination of real-time tonic and phasic 
dopaminergic release providing indications of total neuronal load using a high K+ flush 
and then recovery. This could provide more direct correlations between 
neurotransmitter content and synthesis enzymes. 
In conjunction to examining different areas in attention circuits, tissue from this 
study should be examined in relation to glutamatergic morphology. Glutamatergic 
neurons project from the nucleus accumbens to the prefrontal cortex, and 
dopaminergic and noradrenergic modulation of these projections also may underlie 
differences in attention. By integrating immunohistochemistry between these measures 
as a multivariate analysis, neural networks of attention may be examined at a holistic 
level. 
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Also, although d-amphetamine is a classic stimulant drug used in ADHD 
treatment, novel pharmacotherapies for ADHD involve non-stimulant drugs. 
Atomoxetine holds particular promise as it is designed to target inattentive features of 
ADHD – a symptom particularly prevalent in FASD populations. Atomoxetine targets 
norepinephrine. Because noradrenergic networks demonstrated the greatest plasticity 
in the current study, drugs targeting this system may have the greatest impact on 
neurodevelopment within the prefrontal cortex during the periadolescent 
developmental window. 
This study aimed to provide further evidence towards dopaminergic and 
noradrenergic impairments and the mechanisms behind common pharmacological 
treatments in FASD. Thus far, amphetamine appears to have a selective impact on DBH 
within the prefrontal cortex. However, examining interactions between different 
neurotransmitter systems could provide a better explanation of networks influencing 
attention and hyperactivity. Understanding the etiology behind FASD and its 
relationship with symptomology and treatment will help guide future therapeutic 
directions for this extremely prevalent and detrimental syndrome. 
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